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  INTRODUCTION 
Evolution has made man to be one of the most complex beings in the world. 
May it be from the beginning of time in accordance with the religious scriptures or 
scientific theories starting with “The Big Bang” what we have learned is that all but 
one essential concept, all living things need food and water to survive.  How does this 
food travel down the path from being ingested to broken down and absorbed to get 
utilized is a complex process. In this entire complex of mechanical systems the Lower 
Esophageal Sphincter is one of the major gateways into the world within our bodies.  
Diabetes Mellitus 
Diabetes Mellitus has been a fast growing concern among humankind for the 
past few decades. However, the existence of this disease dates as far back as 3,500 
years, as recorded in the papyrus by the ancient Egyptians. They wrote about a 
polyuric syndrome, which we presume to be diabetes. Simultaneously, the verdic 
medical treaties of India describe this condition a step further going into classifying it 
as either congenital or late onset. It was Sushrant (an Indian Physician) in the 5th 
century AD who reported this polyuria to be a sweet tasting substance. In the late 90 
AD Areatus of Cappodocia stated, “Diabetes is a wonderful affection being a melting 
down of flesh and limbs into urine.” This disease gained its significance only after 
experimental backup in the 2nd half of the 18th century. (1) 
	  When attempted to define Type II DM we come across a textbook definition 
of, it is a heterogeneous group of disorders characterized by variable degrees of  
a) Insulin resistance,  
b) Impaired insulin secretion and  
c) Increased glucose production. (2) 
There are certain criteria for diagnosing Diabetes Mellitus: 
Fasting Plasma Glucose    > 126mg/dL 
Random Blood Glucose     > 200mg/dL 
Post Prandial Blood Glucose > 200mg/dL during oral glucose tolerance test  
HbAlc       ≥ 6.5% (2) 
Up to 75% of patients with diabetes have been known to experience GI 
symptoms as observed in clinical practice (3). A recent study showed that 25% of 
patients with Type II Diabetes had heartburn and acid regurgitation. (3) 
Diabetes and Gastrointestinal Tract 
Diabetic enteropathy refers to all gastro-intestinal complications of diabetes, 
which may include intestinal complications such as dysphagia, heartburn, nausea, 
vomiting, abdominal pain, constipation, diarrhea and even fecal incontinence. (4) When 
studied deeper, in order to find out the underlying cause, epidemiological studies 
identified the risk factors for developing GI symptoms among diabetic subjects was 
	  associated with their poor glycemic control. (4) When a type II DM patient comes with 
upper GI symptoms, it should lead the physician to consider all possible causes most 
importantly autonomic dysfunction. (5) 
The major cause for diabetic gastroparesis according to textbooks is autonomic 
neuropathy, intrinsic neuropathy, damage to the excitatory and inhibitory neurons, 
elevation of blood glucose, and finally psychomotor factors.  
The so-called Asian Indian phenotype refers to a unique clinical and 
biochemical abnormality in Indians, which include increased insulin resistance, higher 
waist circumference despite lower adiponectin, higher levels of C - reactive protein 
levels. This phenotype makes Asians more prone to diabetes mellitus. (3) 
Gastroesophageal Reflux Disease (GERD) 
 The high-pressure zone created by the lower esophageal sphincter protects the 
esophagus against reflux from caustic gastric contents. (5) When this mechanism is 
breeched it gives rise to a group of symptoms, which may be classified under Gastro-
Esophageal Reflux Disease. In the above said condition there is presence of chronic 
relapsing reflux of stomach contents into the esophagus provoking symptoms and/ or 
complications. (6) These will present as symptoms such as heartburn and regurgitation. 
In a commonly based survey of randomly selected individuals 20-40% has 
experienced reflux like symptoms during a six to twelve month period with variable 
	  intensity and frequency. However this reflux becomes pathological when symptoms 
impair quality of life.  
GERD is the consequence of an impaired anti reflux barrier of the lower 
esophago-gastric regions. Due to the copious amount of exposure of the lower 
esophagus to gastric components like pepsin, acid and bile, reflux symptoms result.  
 It was believed until 1982, until proven by Dodds et al, that the main 
mechanism for GERD was not the defective LES pressure. However, it was shown 
that the majority of GERD patients had reflux during Transient Lower Oesophageal 
Sphincter Relaxation (TLOSR).  TLOSR are prolonged relaxations of the LES despite 
there being no swallowing.  
 These TLOSR are from stimulation of gastric vagal afferents, which result 
from distention of the stomach, more specifically the sub-cardial region. This 
distention of the stomach may be due to presence of free air, inflation of an intra-
gastric balloon or an ingested meal. The presence of stretch receptors in the sub-
cardial region may be held accountable to mediate the response to distention. It is 
hypothesized that there is presence of a vagovagal reflex pathway. These vagal 
afferent fibers synapse in the nucleus tractus solitaries (NTS), which in turn activate 
motor neurons in the dorsal motor nucleus of the vagal nerve thereby relaxing the 
LES. It was also believed that these pattern generators in the brainstem also sent 
projections to the nucleus of phrenic nerve, present in the spinal cord inhibiting the 
crural diaphragm. (5) 
	   This normal process of motility of the gastro intestinal tract, and the tonically 
active lower esophageal sphincter, which physiologically relaxes upon swallowing, 
gets disturbed resulting in GERD. This GERD as mentioned above is due to failure of 
the anti-reflux barrier, causing increased exposure of the esophagus to gastric acid, 
resulting in symptoms. Therefore, it is found that gastro esophageal reflux disease is 
one of the most common disorders of the upper GI tract. (4) 
Knowing that the problem lies in diabetic patients who along with the general 
population enter the OPD come with symptoms of heartburn, these patients were 
subjected to high-resolution manometry. It is evident that the lower esophageal 
sphincter pressure can be determined by means of high-resolution esophageal 
manometry. Therefore, in order to study the LES pressure in both diabetics and non-
diabetics who present with heartburn high-resolution esophageal manometry was used 
in this study.  
This, high-resolution manometry reveals the dynamic action of the upper 
esophageal sphincter, the segmental character of esophageal peristalsis and the 
functional anatomy of the esophago-gastric junction. HRM makes it practical to use 
as it gives good quality pressure measurements from the esophagus. (7) With the 
assistance of this tool, it becomes easier to know if there is a relationship between the 
presence of diabetes in patients who present with heartburn.  
While initially framing my research question, I found many discrepancies 
between various studies that were conducted among diabetics and non-diabetics with 
	  acid reflux. I was curious as to why such controversies existed. In the back of my 
mind I wondered if race and ethnicity of the study population that I was going to 
study made a difference. There were studies which were done in Asia, however not 
many pertaining to South Asia and more specifically the South Indian population. If 
data was collected and analyzed in the South Indian population it will help in devising 
treatment options and early detection methods to those in the general population, as 
diabetes mellitus and GERD is one among the most prevalent diseases in today’s 
communities. Due to the paucity of studies conducted in this topic and multiple 
controversies it is better to have more data collected so that a definitive conclusion 
can be arrived at.  
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  AIM: 
To evaluate the Lower Esophageal Sphincter Pressure in patients with Type II 
Diabetes Mellitus, presenting with heartburn, by esophageal manometry studies. 
 
OBJECTIVES:  
1. To find the correlation between the severity of the GI symptoms and severity 
of type II diabetes mellitus by use of glycemic index.  
2. To determine whether these tests can be used as early indicators of GERD 
(Gastro-esophageal Reflux Disease) in patients with Type II Diabetes Mellitus. 
3. To study the pathophysiology of gastro esophageal reflux symptoms in patients 
with type II diabetes.  
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  Review of Literature 
 Diabetes Mellitus, in today’s world is everyone’s worst feared disease. 
It is treatable however not curable, for this one lifelong imposition on one’s health 
one tends to fear this disease. With its fast growing spread across the world, more 
specifically India, in 2014 a study conducted by Kaveeshwar et al found that more 
than 62 million suffer from this disease. In the year 2000, India held the largest 
population with diabetes, at 31.7 million, followed by China and finally the United 
States of America. (8)In a meta-analysis conducted in 2015 Sun et al and team found 
that patients with diabetes mellitus are at greater risk of developing gastro esophageal 
reflux disease than those who don’t have diabetes. They also concluded that in their 
findings they saw that there was a greater association in patients over the age of 50 
years and the Asian population being at risk for gastro esophageal reflux disease in 
those who have diabetes. (9) With these facts in mind it is important to understand the 
pathogenesis of this disease by studying the basic anatomy and physiology of the 
upper gastrointestinal system.  
Lower Esophageal Sphincter (LES) 
The Lower Esophageal Sphincter is a physiological sphincter placed between 
the lower end of the esophagus and the stomach. This junction consists of three vital 
elements, initially the esophageal smooth muscles, which are more prominent towards 
the stomach, are known as intrinsic sphincter. The second element is the fibers of the 
crural portion of the diaphragm. Finally, fibers from the stomach known as sling 
	  fibers create a flap valve that closes the esophageal gastric junction. (1) There are some 
specific functions of the lower esophageal sphincter, one of which is to prevent 
significant acid reflux from the stomach along with its contents. There lies a valve-
like mechanism, which extends from the esophagus into the stomach; this specialized 
mechanism also helps prevent reflux. (10) 
Although the integrity of this lower esophageal sphincter is highly maintained 
in normal beings there arises a possible breech in this perfectly functioning one-way 
path physiologically. One may wonder how is it physiologically possible for this LES 
integrity to be compromised and still be considered normal. The mechanism of 
belching and vomiting are physiological mechanisms that alter the LES integrity to 
allow air or food to deviate away from this one-way pathway. This is made possible 
by the high-pressure zone present around the lower esophageal sphincter. The high-
pressure zone keeps the gastro esophageal junction closed, but a brief relaxation due 
to inhibitory neurons permit passage of material through this physiological sphincter. 
Innervation of the Esophagus 
The esophagus is innervated primarily by the vagus nerve. They are of two types, the 
somatic motor which arises from the nucleus ambiguous. The second is the visceral 
motor type starting from the dorsal motor nucleus. Both these nerves are found to 
synapse at different areas, the somatic motor nerves are found to synapse directly with 
the striated muscle fibers of the esophagus whereas the visceral motor nerves synapse 
with nerve cell bodies that lie between the longitudinal and circular muscle layers. (11) 
	  These motor innervations has neurons which may either decrease or increase the tone 
of the LES by stimulation of inhibitory or excitatory motor neurons in the myentric 
plexus located in the LES. Theoretically the vagal nerve has innervations to both 
excitatory and inhibitory myentric motor neurons, however experimental protocols 
generally show LES relaxation. (5) 
Upper esophageal sphincter is tonically contracted to seal the esophagus during 
rest. During swallowing these tonic contractions fails to appear for less than one 
second, this is in order for all the bolus to enter into the esophageal lumen. How does 
its tonic state of contraction exist during a period of rest? It is the result of the somatic 
motor nerves that excite contraction of this muscle. Therefore swallowing needs to be 
during a period of relaxation, where this state of contraction is transiently suppressed. 
The origin of this nerve is from the motor nuclei in the brainstem, which traverses as 
the tenth cranial nerve. (12) The tone of the LES is controlled by the neural pathway. 
The relaxation and contraction (maintenance of the tone) to keep the LES is 
controlled by the discharge of acetylcholine from vagal nerve endings, causing the 
latter. The release of nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) 
from the interneuron cause the LES to relax. The phrenic nerves coordinate 
respiration along with the contraction of the chest and abdominal muscles. This active 
complex mechanism contributes to the maintenance and working of the lower 
esophageal sphincter. (13) The LES has an approximate length of four centimeters. This 
high-pressure zone in healthy individuals generates a tonic pressure of about 15-30 
	  mm of Hg above the intragastric pressure, this account for ninety percent of the basal 
pressure at the gastro esophageal junction. (5) 
 The esophagus propels the food through the lower esophageal sphincter into 
the stomach. This lower esophageal sphincter prevents reflux of gastric contents. The 
esophageal gastric mucosa contains a protective squamous epithelium, which prevents 
significant diffusion or absorption. This propulsive movement is strictly aboral, 
relaxing the upper and lower esophageal sphincters during swallowing. (2) 
 Central control of swallowing will send a series of sequential impulses to 
progressively distal segments within the esophagus. As a result of these peristaltic 
contractions occur. Even with bilateral vagotomy (cutting of the vagus) peristalsis can 
occur with the aid of the intrinsic nerve plexus or smooth muscle cells themselves. 
The intrinsic properties of smooth muscle fibers regulate the LES contraction, along 
with neural and humoral influences. The smooth muscle in response to passive 
stretching will contract in order to oppose the stretch.  
An example of this is the increased resting tone by cholinergic agonists and by 
gastrin a gastrointestinal hormone. However, the sphincter tone is decreased by 
prostaglandin E1 and isoproterenol. (11) The excitatory myentric neurons, which are 
present in the LES, are cholinergic and act to stimulate muscarinic receptors present 
in the smooth muscle. Whereas the inhibitory motor neurons receive cholinergic 
nicotinic inputs from vagal efferent. (14) While the vagus nerve stimulation usually 
results in relaxation, the splanchnic nerve stimulation relaxes the LES by activating 
	  adrenergic neurons through nicotinic and non-nicotinic mechanisms of neural 
transmission. This results in β-adrenergic inhibitory effect on the LES. (15, 16) All these 
factors are experimentally observed in various mammalian experiments. (17) 
Gidda and colleagues in 1984 identified two types of vagal fibers, which were 
differentiated according to its discharge patterns. The two types of fibers had unusual 
latency gradients. The speculation was that the short latency fibers projected to the 
inhibitory myentric neurons whereas; the long latency fibers projected to the 
myenteric excitatory neurons. (18) 
 The neurochemical basis for transient lower esophageal sphincter relaxation is 
hypothesized to be due to vasoactive intestinal polypeptide (VIP) and nitric oxide 
(NO) as stated before. (11) The relaxation is mediated through nerves, which act by 
releasing VIP or NO. Along with this, increase in intragastric pressures further 
constricts the sphincter as mentioned above through vagal reflex. Gastrin released in 
excessive amounts, more than within physiological limits, also increase the tone of the 
sphincter. (19) 
Physiology of Peristalsis  
By peristalsis material is propelled from the pharynx to the stomach by means 
of a tube like structure, known as the esophagus. (11) The esophagus is divided into two 
separate parts. The cervical esophagus being the first part, which consists of, striated 
muscle. The thoracic esophagus is the second part, which is made up of smooth 
	  muscles. (20) The movement of the bolus is carried out by coordinated contractions of 
muscular layers within the esophagus. (14) In 1883 Kronecker a German scientist and 
his medical student Meltzer investigated how food is transported through the 
esophagus. (20) They concluded that the bolus was pumped by the tongue into the 
esophagus. The esophagus to them was only a passive channel for the transportation 
of the bolus into the stomach. (20) However, what would happen to food or water if 
swallowed in a recumbent position? A scientist named Ingelfinger observed this by 
means of fluoroscopy upon a barium bolus swallow with a head down position. This 
is when he came up with the concept of a peristaltic wave carrying the bolus into the 
stomach. (20) Due to a large portion of the esophagus being present in the thorax, where 
pressure is lower than the pharynx and stomach, the esophagus can withstand the 
entry of air and gastric contents. The esophagus is protected at both ends by the 
presence of sphincters on either end. With the help of pressure sensing devices at 
various levels of the esophagus, monitoring of pressures during swallowing is 
achieved. This helps to indicate that between swallows, both upper esophageal 
sphincter and lower esophageal sphincter are closed and the body of the esophagus is 
flaccid. The contractions begin when a bolus is swallowed, with a contractile wave 
moving towards the stomach. The velocity at which the contractions move down the 
esophagus is very slow, around 2-6cm/sec, it can even take up to 10 seconds for it to 
reach the lower end of the esophagus. (11) 
	  The esophagus carries out two types of peristaltic movements. This is 
classified into primary peristalsis and secondary peristalsis. The primary peristalsis is 
follow-up movement from the pharynx, which takes place at the end of the pharyngeal 
stage of swallowing. From the pharynx to the stomach this movement takes about 8-
10 seconds. When the primary peristalsis is incomplete and leaves food in the 
esophagus, due to the distention in the esophagus caused by the retained food, 
secondary peristalsis begins. (10) The initial wave relaxes the esophagus in order to 
accommodate the bolus; this is followed by a wave of contraction, which propels it. If 
the individual is upright then gravity will aid in the peristalsis. (21) 
 The control of sphincters opening and closing is quite a complex, coordinated 
set of events. The peristalsis which occurs in the striated part of the esophagus is 
controlled by the swallowing center in the brain stem. Central mechanisms through 
experimental studies proved to be the only pathway for esophageal peristalsis. In an in 
vitro mammalian setup electrical stimulus gave rise to a tetanic type of contraction, 
which was terminated only upon stoppage of stimulus. On the other hand, in an in 
vivo setup swallowing evoked a peristalsis, but electrical stimulation of the vagal 
efferent produced non-peristaltic tetanic contractions. (16) This proved that the control 
was central. (11) Christensen and team et al in the 1970s found that the esophageal 
smooth muscles were inhibited during the period of stimulation and that contraction 
took place only after, as a rebound phenomenon. This rebound was after stimulation 
of the inhibitory nerves. He also made a discovery that the walls of the smooth muscle 
	  part of the esophagus had an inbuilt latency gradient. This showed that the longest 
latency of contraction was in the proximal part of the esophagus and the shortest 
latency was towards the distal end of the esophagus. The inhibitory nerves were found 
to be responsible for the peristalsis in the esophageal smooth muscle portion. (12) 
Closure of the upper esophageal sphincter is by the normal elasticity of the 
sphincteric structures and the active contraction of the cricopharyngeal muscle. As 
such the relaxation of the upper esophageal sphincter is coordinated with the 
contractions of the pharyngeal muscles. The relaxation of this muscle is brought about 
by suppression of nerve impulses from the swallowing center through the activity of 
the nucleus ambiguous. The cricopharyngeal area is displaced. The displacement will 
cause the sphincter to open. (11) 
Gastroesophageal Reflux Disease (GERD) 
 When this normal tone is deviated, the patient becomes symptomatic. 
Alteration above normal will cause a hypertensive sphincter. When a bolus is 
swallowed there is failure of relaxation, because of a hypertensive sphincter, 
producing a condition known as achalasia. Here esophageal peristalsis is absent and 
the resting LES tone is elevated. The above motor abnormalities lead to accumulation 
and retention of saliva and food within the esophagus. Symptomatically the patient 
will have dysphagia to both solids and liquids and regurgitation. This may finally lead 
to malabsorption and weight loss. (5) Histological evidence reveals a decrease in the 
number of myentric neurons, more specifically inhibitory NO releasing neurons. The 
	  reason for this decreased count remains unknown. While this is one end of the 
spectrum in the other end lies a hypotensive sphincter. Therefore when the LES is 
hypotensive or lax it results in a series of symptoms. Pyrosis, heartburn, is the most 
common feature seen in hypotensive sphincter. This is characterized by a burning 
sensation or discomfort behind the sternum, this sensation arises from the epigastrium 
and radiates all the way up to the neck at times. (21) Heartburn is most commonly 
experienced after eating, while in a recumbent posture or during vigorous exercise. 
Katzka et al found in a national survey that up to 40 percent of adults suffered from 
heartburn. (22) 
 The pathophysiology of heartburn is due to dysfunction within the lower 
esophageal sphincter. As mentioned previously, the barrier, which prevents reflux 
acid travelling backwards, is the high-pressure zone. This zone is between the low 
pressures of proximally the esophagus and distally the stomach. Abnormalities in this 
baseline tone of the sphincter or prolonged opening of the LES will lead to heartburn. 
The most common reason for the patient being symptomatic is due to a term, which 
was introduced before, transient lower esophageal sphincter relaxation (TLOSR). The 
LES will relax and eliminate the existing pressure gradient between the stomach and 
esophagus. Prolonged TLOSR is not the only cause, along with these factors which 
cause predisposition for severe gastro esophageal reflux disease (GERD) is a 
hypotonic LES, where the tone is persistently low.  
	   The lower esophageal sphincter plays an important role in the pathogenesis of 
GERD. Motility helps in removing the acidic reflux from the esophagus back to the 
stomach. Here we find that when the motility is reduced the esophagus remains 
exposed to acidic reflux for longer duration of time, and is unable to return back to the 
stomach and progress onwards. This disturbance in motility leads to delayed gastric 
emptying, which creates a higher opportunity for reflux to take place. The esophageal 
mucosa is not only exposed to acid from the stomach but also bile and pepsin. The 
combination of the above mentioned products with acid cause major harm to the 
esophageal lining epithelium. All these factors lead to discomfort, and a retrosternal 
burning sensation, most commonly referred to as heartburn. (23) 
 A less known fact is that the saliva contains many components, one of which is 
epidermal growth factor that has healing properties. Lack of this in saliva will lead to 
the esophageal mucosa lacking a major defense mechanism. On the contrary, 
concomitant to the onset of heartburn the individual will experience excessive 
salivation as a consequence of a triggered vagal reflex leading to acidification of the 
esophageal mucosa. The patient describes this event as an unpleasant sensation within 
the mouth. The mouth rapidly fills with a salty thin fluid. This is known as water 
brash. (23) 
Another common presentation is regurgitation that is specifically due to a lax 
LES. Regurgitation is defined as the effortless return of food or fluid back into 
pharynx in the absence of nausea or retching. When the patient bends forward, 
	  belches or maneuvers in ways, which increase the intra-abdominal pressure, this will 
bring forth a sour burning fluid in the throat or mouth which at times may even 
contain undigested food particles. (23) 
 With these symptoms in mind, a classification was made. Here with, arises a 
term referred to as GERD which encompasses all of the components that are 
symptoms and or lesions caused by the reflux of gastric contents. (23) While it is 
known that some degree of gastro esophageal reflux is normal, physiologically 
intertwined with the mechanism of LES relaxation, but excessive reflux leads to 
esophagitis accompanied by an impaired clearance of refluxed gastric juice. 
Even though many patients experience a variety of symptoms all over the 
world, for a long period of time there were no clear guidelines or definition for reflux 
symptoms. Finally to make it easy for primary care physicians all over the world to 
classify and grade these symptoms they came up with a solution. Through modified 
Delphi process a consensus definition of GERD was formed. This was not done in an 
easy way. The principal steps in this process were first the selection of a consensus 
group and the development of a draft of statements. This was followed by a systemic 
overview of literature to pinpoint the evidence to support each individual statement 
and a grading was prepared in accordance with the evidence. Finally a voting 
discussion repeatedly was done anonymously on the series of iterations of statements 
until a consensus was achieved. (24) 
	  The exact definition of Gastroesophageal Reflux Disease, which has been 
universally accepted, is by the Montreal Consensus. “A condition, which develops 
when reflux of stomach contents causes troublesome symptoms and/ or 
complications.” One may want further clarification as to what defines the term 
“troublesome”, which they go about to further state that it is negatively affecting an 
individual’s sense of wellbeing. (24) It also satisfactorily describes the negative 
characteristics of the symptoms from a patient’s standpoint, and allows the definition 
to be translated into various languages. Those who defined this consensus recognized 
the symptoms of GERD to be retrosternal burning (also known as heartburn) and 
regurgitation. This classification was made so simple that it allowed patients to be 
diagnosed not only by typical symptoms alone or on the basis of investigations, which 
prove reflux of stomach contents. (24) One may wonder how often these “troublesome” 
symptoms appear, in a population based study, mild symptoms which appear two or 
more days a week, or moderate to severe symptoms, occurring more than one day a 
week fall into this definition. 
Diagnostics 
	   The symptoms which the patient experiences most commonly heartburn 
and regurgitation may be further acknowledged by diagnostic testing. Heartburn can 
be interpreted in many ways; this depends on where they live and how they express 
that sensation to the physician. Therefore, the consensus defined heartburn as a 
burning sensation behind the breastbone in the retrosternal area.  Regurgitation was 
	  more specified as the perception of flow of refluxed gastric content into the mouth or 
hypopharynx. (24) The gold standard for monitoring reflux is an ambulatory pH-
monitoring device. (25) Esophageal manometry is mostly used for the diagnosis of 
dysmotility but has some use in the diagnosis of GERD. It is known that in GERD 
that there is disruption of the anti-reflux barrier and esophageal peristalsis. The only 
drawback is that there is no pathognomonic manometric pattern for reflux. (26) 
The basics of manometry are that, pressure patterns that drive a bolus transport 
during a particular period is measured and recorded. (27) Intra- esophageal pressure 
measurements were started in the late 19th century. Initially there were balloon tipped 
catheters, which were used for animals and humans for the measurement of pressures. 
The basic balloon kymographic method had a water manometer to record the volume 
changes, which took place. This was connected to an intra luminal balloon. They 
found that this method was highly inaccurate as the pressure changes recorded were 
of the balloon and not the intra luminal pressures. The balloon also caused a 
hindrance to the water or solid, which was being swallowed by the studied subject. 
This primitive method was overcome by the use of miniature balloons that were 
mounted over a micro transducer or was directly placed to the end of an open tipped 
catheter. Further modifications occurred by making the balloon material polyester, 
which was non-distensible. This preserved the original shape and diameter of the 
balloon. With this they were able to execute accurate and pull through measurements 
in the sphincter. (28) During the first part of the 20th century non-perfused, open-tipped 
	  catheters were placed to measure pressure and propulsive contractions by Brody and 
coworkers. These catheters slowly started to evolve; introduced next was a pneumo-
hydraulic perfusion system with side holes on the catheters. This method showed that 
the measurements were more accurate. (29) 
There are many types of manometry systems present, however the basic 
concept is that the data is recorded digitally to a computer and analyzed. The pressure 
recorded is transmitted through a pressure signal to the computer. The pressure 
recorded is the intra-luminal and wall contact pressure. Factors, which need to be 
taken into consideration in order to make sure the readings are precise, are the spacing 
and orientation of the pressure sensors, the rate of increase in pressure which is being 
recorded, the accuracy of the measurement being taken and finally the rate of 
digitization of the signal being transmitted. (30) 
Manometric studies are carried out for two reasons, one may be to aid in 
clinical diagnosis and the other is to provide data for research purposes regarding the 
functioning of the gastrointestinal system. Three characteristics of recording are 
obtained while performing manometry. Spatial resolution is the distance between the 
recording points, temporal resolution that is the rate of pressure measurement 
sampling and finally the accuracy of what is being measured.  
Two types of manometric recording systems are available. They are 
distinguished by the location of sensors within the catheter itself or its placement 
externally. When the sensors are placed externally, the pressures are transmitted along 
	  a column of water perfused slowly through the catheter. In either case, the signal is 
digitized and recorded by means of a computer.  
Most of the South Asian studies have used external transducers, which are 
water-perfused. This is due to its low cost and easy maintainability when compared to 
the intra luminal transducers. Even though this type of transducers is easy to use and 
the dynamic performance of these systems is excellent, the catheter is expensive and 
delicate. They are usually stiffer than the water perfused catheters and are sensitive to 
temperature change. Small temperature changes cause fluctuations in the pressure 
recorded. This will alter the baseline of the individual’s recordings.  
The water perfusion system contains transducers placed externally, so when 
water passes through them by a pneumo-hydraulic pump the rate at which the water 
flows within each channel is measured. This determination of the water flow is by 
means of the resistance of a capillary, placed upstream from the catheter. Due to this 
the flexibility of the thinner catheter patients feels more comfortable during the 
procedure.  
Generally, the pressure measured by means of manometry is not continuous 
even though this would be ideal for accuracy. However, this is not possible therefore; 
recordings at a distance of 1 cm are considered adequate across the pharynx and lower 
esophageal sphincter. The ideal distance for recording within the body of the 
esophagus has not been determined therefore we go by the commercially available 
	  systems, which record at a distance of 1-3 cm. A pressure recorded at a frequency of 
25 Hz or above provides an ideal temporal resolution. (30) 
In order to determine the accuracy of the pressure measurement recordings, 
various factors need to be taken into consideration. The characteristics as mentioned 
above, the placement of the transducers, pressure artifacts during recording, and 
mechanical factors. To further explain what those mechanical factors are we can 
consider the changes in the pressure which drive the pneumo-hydraulic pump and the 
effect of the perfusion bubbles through the capillary resistors, which are present 
within the lumen of the catheter. Transducer drift is another factor, which can alter the 
accuracy. This is the instability in the baseline pressure, which is recorded through the 
transducer. As mentioned before, this may be caused by minute temperature changes 
or electrical activity.  
In order to calibrate this device a known pressure to the transducers are applied 
and recorded. Pressures should rise in each transducer equally and should remain 
constant for a period of 20-30 minutes of recording. This can be accomplished by 
placing the transducers within a water bath to simulate placement within the 
gastrointestinal tract.  
The artifacts, which may arise in the pressure recordings, may be due to 
multiple reasons. One of which is the compression of adjacent structures such as 
blood vessels and liver. Another reason may be due to the catheter bending within the 
GI tract and its compression on the wall of the tract. Faulty transducers can cause 
	  electrical disturbances to appear as artifacts. According to need the catheter should be 
repositioned in order to get an ideal reading.  
Upon recording and viewing on the computer screen the live feeds, the catheter 
will show physiological structures such as the lower esophageal sphincter as increased 
pressured areas. Deep breathing and swallowing during a recording of esophageal 
manometry can accentuate the physiological features such as the position of the 
diaphragm or presence of the sphincter. The recording can be viewed as either a 
spatiotemporal topographic color plot or a line plot. The analysis software will allow 
the doctor to view pressures at any point and time of recording. These recordings are 
displayed as spatiotemporal topographic plots. This software will include the ability to 
measure particular aspects of the gastrointestinal function, which has to do with the 
region being observed in relation to certain events such as swallowing. (30) 
Verma et al states the purpose of esophageal manometry is that it will take a 
close look into the functional integrity of the portions of the upper gastrointestinal 
tract, which have to do with entry of bolus. (30) Yadlapati et al in an in a question 
answer session commented that initially the conventional manometry which was used 
had five pressure sensors spaced widely apart, compared to which we use now, a 36 
pressure sensor catheter spaced 1 cm apart. The only advantage of the older 
conventional version was it’s the cost effectiveness; however this is nothing in 
comparison to the accuracy achieved by high-resolution manometry. (31) The two-
dimensional conventional plots consisted of the y-axis subjected as pressure and x-
	  axis subjected as time. The difficulty lies in the exact placement of the catheter in the 
lower esophageal sphincter. (30) 
Wyle Jerry Dodds and Ron Arndorfer first devised the first high fidelity 
manometry system in the 1970s. This method was used for almost 20 years before 
Ray Clouse modified it in the early 1990s-giving rise to the new high-resolution 
manometry (HRM). The spacing between each sensor was 1 cm and the numbers of 
pressure sensors were increased along with an increase in the length of the catheter. 
With these modifications, it was made possible to visualize both the upper and lower 
esophageal sphincters with each swallow. This provided a complete spatial and 
temporal depiction of the motor function of the esophagus. (32) What made a huge 
difference in the recording and analysis portion of HRM was that they added a third 
axis to the existing 2-dimentional plot; the z axis stacked the pressure waves giving 
birth to a topographical graph. The z-axis contained gastric pressures to the front and 
pharyngeal pressures in the back of the topographic graph. Amplitude was changed to 
the y-axis and time on the x-axis remained the same. Clouse and team color 
coordinated the pressures and gave it a 3 dimensional contour. The low pressures 
were blues and greens and the high pressures were of red and yellow spectrum. (32) 
The most important and crucial landmark in esophageal HRM is the esophago-gastric 
junction. This junction consists of the lower esophageal sphincter and the crural 
diaphragm. The basic terms, which need to be identified when dealing with HRM, are 
as follows and these terms will be interrelated into the Chicago Classification. (31) The 
	  Chicago Classification sorts esophageal motility disorders according to its high-
resolution manometry topographic plots. These are also known as Clouse plots, 
named after the founder of HRM Ray E Clouse. (33) 
Fig 1: High-resolution oesophageal pressure topography (Clouse plot) 
 
Hani et al and colleagues opinioned that the edge which the HRM had over the 
conventional type of manometry, was that simultaneous view of the upper esophageal 
sphincter, the esophageal body and the lower esophageal sphincter was made 
possible.  
This made HRM have a complete representation in time and space of the motor 
function of the entire esophagus. Through HRM they go further to support that, 
occurrence of reflux events can be predicted and the components of the anti-reflux 
barrier can be made quite evident. (34) 
	  Interpretations of the high-resolution manometry (HRM) will initially begin 
with the evaluation of the resting pressures of the upper and lower esophageal 
sphincters. These are easily identifiable because of their drastic color change from the 
normal color contour on the screen. As mentioned previously the high-pressure areas 
of the upper and lower esophageal sphincter take up pink and red shades.  The below 
diagram depicts the presence of the upper and lower esophageal sphincter, as well as a 
term identified as PIP (pressure inversion point). This PIP is the point at which the 
negative pressure caused by the intra thoracic pressure changes to positive pressure, 
which is caused by the intra-gastric pressure. In other words, it is the division caused 
by the diaphragm separating the chest and the abdomen. (34) 
Fig 2: UES& LES depicted by differentiating  
colors with identification of PIP 
 
Basal lower esophageal sphincter pressure is the high pressure zone in 
normal individuals which is above the intra-gastric pressure that accounts for about 90 
	  percent of the basal pressure which is evident at the gastro esophageal junction. (5) 
This was said to be recorded and found to be around 29.35 mmHg and the mean EGJ 
relaxation pressure was 16.79 mmHg in a study conducted by Bogte et al. (27) 
Niebisch et al states in an article that the normal values for esophageal high resolution 
manometry are although essential are limited. The objective of his study was to 
provide a second set of ‘normal values’ to support the existing metrics. The 
assessment of the esophageal gastric junction is a high-pressure zone. This is 
represented by the LES and crural diaphragm complex, which is recorded for a 30 
second landmark frame during which the overall length, resting pressure are 
determined. From the above study they concluded that the LES pressure (respiratory 
mean) was to be 27.9 ± 11.5 mmHg. The range of this pressure was noted to be 12.3 
mmHg – 52.2 mmHg. (35) Due to this wide variety of normal ranges provided it is 
suggested by many specialist that each center create its own standardization and range 
of normal values. In our institute we have taken to the normal values to be from 10 – 
35 mmHg for the Basal LES pressure. When the value is below 10 mmHg it is 
considered as reduced and above 35 mm of Hg it is classified as elevated. Any values 
between these are considered as being normal.  
 Basal Inspiratory and Basal Expiratory Pressure. The end expiratory 
sphincter pressure (basal expiratory pressure) is a more accurate reading rather than 
the Mid-respiratory lower esophageal sphincter pressure because this value includes 
many respiratory artifacts and does not accurately measure the lower esophageal 
	  sphincter pressure. (36) During manometric profile the LES pressure is represented by 
an increase in pressure during inhalation. This increase in pressure is due to the 
contraction of the diaphragm, which surrounds the esophagus. (37) Therefore the 
normal range of basal expiratory pressure is said to be the basal lower esophageal 
sphincter pressure of 10-35 mm of Hg.  
Median Integrated Relaxation Pressure (IRP) signifies the mean EGJ 
pressure during a 4 second continuous or non-continuous window after deglutition 
relaxation of the upper esophageal sphincter. (30) This median IRP is in simpler terms 
the assessment of the LES relaxation. (34) In order to measure the integrated relaxation 
pressure the EGJ junction should be pinpointed. In the region of the EGJ from the 
opening of the upper esophageal sphincter gives a deglutition window of 10 seconds. 
Inside this window period the computerized software gives the lowest mean pressure 
for those 4 seconds. The software excludes the pressure created by the crural 
diaphragm and the bolus itself. (30) A value of the median IRP being greater than 15 
mmHg can be considered as an increased resistance to bolus transit at the esophago-
gastric junction, and this can be interpreted as being pathologic. (34) 
Fig 3: Integrated Relaxation Pressure (IRP)  
 
	  EGJ –CI 
Esophago-gastric junction contractile integral (EGJ –CI) is an assessment of 
the EGJ barrier function on esophageal high-resolution manometry (HRM). The value 
is measured by the following means: esophago-gastric junction contractile integral 
(mmHg.cm) is calculated by using the distal contractile integral measurement across 
the EGJ, measured above the gastric baseline and corrected for respiration. The 
median IRP assess only the gastroesophageal junction in conditions of post swallow 
residual pressures, along with the adequacy of transit through the junction, which 
comes along with the swallow. The median IRP however does not take into account 
the anti reflux barrier function of the gastroesophageal junction. The EGJ contractile 
integral is a novel HRM metric that evaluates the EGJ barrier function. (38)
 Determination of the peristaltic activity needs to be noted; it will be either 
normal or failed. This depends on the pressure extending over 2-5 cm, which is 
labeled as short peristaltic defect, or if it is greater than 5 cm it is labeled as long 
peristaltic defect. The minimum pressure of 20 mmHg was chosen because it is the 
lowest pressure at which the esophago-gastric junction works adequately.  
       Fig 4: Long Peristaltic Defect >5 cm      Fig 5 : Short Peristaltic Defect 2-5 cm 
     
 
 
	  Next what is evaluated is the strength of the contraction created within the 
esophagus. This is labeled as Distal Contractile Integral (DCI). The term distal is 
used because of the measurement taken from the distal segment of the esophagus. It 
can also be denoted as the amplitude x duration x length (mmHg-s-cm) of the distal 
esophageal contraction. A value more than 20 mmHg from the proximal to distal 
pressure will be shown as troughs in the graph. 
Another most commonly used term is the contractile deceleration point 
(CDP), which is the location in the lower esophagus in which the velocity of 
peristaltic contraction reduces suddenly. This is due to the fact that the bolus will 
empty into the stomach at certain points along the entire length of the esophagus. Due 
to this esophageal emptying the resistance offered by the EGJ will slow down the 
velocity of peristaltic waves. The speed of the peristaltic wave is determined and 
labeled as contractile front velocity (CFV). The software calculates the slope of the 
line between the transition zone and CDP. Its normal value should not exceed 
9cm/sec.  
Fig 6: High resolution Manometry showing: Contractile deceleration Point 
(CDP) Contractile Front Velocity (CFV) 
 
	  The final term is the distal latency (DL), this is identified as the time taken 
from the beginning of the upper esophageal sphincter relaxation to the CDP. This 
helps identify the peristaltic timing and period of deglutition inhibition. Another 
concept, which needs to be noted, is something referred to as a peristaltic break. It is a 
measure of the peristaltic integrity of the esophagus itself. In order to identify this, an 
isobaric contour line of 20 mmHg needs to be drawn. 20mmHg as the contour line 
was decided upon by simultaneous fluoroscopic imaging, which correlated with the 
minimum pressure, required for successful transfer of bolus. (30) Breaks along this line 
shows that a hypotensive peristalsis leads to failed bolus transit. These breaks can be 
classified as small (2-5 cm) or large (>5cm).  
When a deeper look is taken into the analysis portion of esophageal manometry 
according to the Chicago classification the upper limit for IRP is 15 mmHg. Any 
pathological condition that hinders flow across the EGJ can increase the IRP. Such 
examples are achalasia, neoplasm or strictures at the EGJ. The evaluation of the 
propagation of the pressure values can be either with the contraction front velocity 
(CFV) or the distal latency. The CFV is a measure of the velocity in the smooth 
muscles of the esophagus to the point of CDP as mentioned before. This CFV can 
appear rapid in a case in which the bolus is pressurized in-between the EGJ that 
doesn’t give way and a peristaltic contraction. The normal CFV should not go beyond 
9 cm/sec. According to the Chicago classification a short DL, which indicates an early 
arrival of the esophageal contraction to the distal esophagus, is considered more 
	  reliable in diagnosing distal esophageal spasm rather than the CFV. The recorded 
lower limit for the DL is 4.5 seconds.  
DCI measures the robustness of the peristaltic contraction within the smooth 
muscle of the esophagus. In case of HRM the DCI integrates pressures, distance and 
time taken along the course of the esophagus. It is essentially takes into account the 
mean contraction amplitude of the smooth muscle of the esophagus, the length over 
which the contraction propagates and the duration of this contraction.  
Absent peristalsis is portrayed by a normal IRP and no peristalsis in the smooth 
muscle within the esophagus. This pattern may be indicative of many conditions 
including diabetes mellitus, especially if the patient complains of being symptomatic 
from gastro esophageal reflux disease accompanied by absent peristalsis. (32) 
To take a deeper look into the EGJ tone in a HRM recording, there is a robust 
phasic section during normal respiration, which is connected with the crural 
diaphragm contraction, which takes place during inspiration. Due to this large 
measure the effect of respiration needs to be accounted for. In order to eliminate this 
concern both the inspiratory and expiratory EGJ pressure averaged over 3-5 
respiratory cycles are taken within reference to the intra-gastric pressure.  The LES 
pressure integral was found to be lower in patients with pathological esophageal acid 
exposure when compared with normal esophageal acid exposure. The current 
statement stands that the best method to assess the EGJ pressures is an average of 
inspiratory and expiratory values for three normal respiratory cycles. (33) 
	  Body Motility refers to the esophageal body peristalsis. It can be classified to 
be either as propagative which is normal or ineffective. This is determined by the 
powerful peristaltic contraction, which will tell us about the integrity of the neural 
innervations of the smooth muscle. The measured amplitude of the contraction is 
determined between the balance of intrinsic excitatory cholinergic and inhibitory 
nitrergic to the musculature. The vagal afferent neurons are influenced by the bolus, 
which transits in the esophagus sending signals to the solitary nucleus where the vagal 
motor efferent will initiate the smooth muscle action. Ineffective esophageal motility 
is characterized in HRM by a DCI value of <450 mmHg/s/cm (weak contraction) or 
value < 100 mmHg/s/cm (failed contraction). Chen et al states that ineffective 
esophageal motility is very common in patients with GERD who come with 
dysphagia and heartburn. (39) 
There are other means of validating acid reflux. The 24-hour pH monitoring as 
mentioned before is the standardized testing for acid reflux. This device allows direct 
measurement of esophageal acid exposure, reflux episode frequency and the 
association between the episodes with the patient’s symptoms. There are two ways of 
monitoring acid reflux, one is through a wireless capsule and another is by means of a 
trans-nasal catheter. This procedure is usually done with the patient off acid 
suppression medication. For either technique utilized there should not be any change 
in the patient’s diet or routine, in order to capture an accurate day-to-day esophageal 
acid exposure. (25,40) Some of the advantages of wireless capsule are that the patient 
	  experiences minimum amount of discomfort. The placement of the capsule is by 
means of endoscopy in the mucosa of the distal esophagus, to be precise it is placed 6 
cm above the squamo-columnar junction. The device is a radio telemetry pH-sensing 
capsule, which measures pH and transmits the data via a radiofrequency signal to a 
small receiver which is attached to the patient’s belt. (41) The fixed position of the 
capsule is at times an advantage and a disadvantage. The advantage is that it doesn’t 
move out of position, as does the trans nasal catheter while swallowing and talking. 
Disadvantage of this capsule is the cost of the device as well as the placement and 
removal of it requires endoscopy both times. (40) Agrawal et al states that over 
diagnosis of GERD sometimes occurs with intake of acidic food items. (42) Chawla et 
al found that when administered propofol prior to placement of the pH capsule, which 
is mostly done in children, there was increased number of episodes of reflux for the 
first 6 hours from placement of device. (43) Another major advantage is the capsule 
allows for longer periods of recording ranging from 2-4 days. Here arises a need for 
these sophisticated testing methods. The reason behind this is due to the substantial 
disease burden of GERD and understanding by the physicians that the patient has 
become unresponsive to proton pump inhibitors (PPI). Therefore, need is to improve 
the monitoring methods for diagnosis and to oversee the outcome after therapy. (44) 
Miguel et al concluded that esophageal manometry and 24 hour pH monitoring 
are effective methods for proving the functional modification, which is achieved by 
anti-reflux surgery. He did this by performing these tests both pre-operatively and 
	  post-operatively. Out of 41 patients who had a hypotonic sphincter on average their 
preoperative pressure reading was 9.2 mm of Hg and postoperatively came up to 
about 15.2 mm of Hg. The pH monitoring showed that a high DeMeester score of 
31.4 was brought down to 3.2 after surgery. (45) 
The other type of monitoring is trans nasal catheter pH testing, here the major 
advantage is that the patient has an added testing known as impedance. There can be 
differentiation between acid and non-acidic reflux. This is done by detecting changes 
in the resistance to electrical current across adjacent electrodes, allowing it to 
differentiate the ante grade and retrograde bolus transit of both liquid and gas. The 
disadvantage of this method is that the patient experiences discomfort due to the 
catheter placement trans nasally. The patient can also only tolerate the test for 24 
hours. Finally an analysis of the symptom-reflux correlation is made. The association 
between the reflux events and the symptoms are calculated. A positive association 
along with abnormal esophageal acid exposure gives evidence that lead to the 
diagnosis of GERD. (24) 
In a study conducted by Häkanson BS and team compared wireless to catheter-
based pH monitoring in 55 patients with GERD and 53 healthy individuals. The 
catheter recorded for 24 hours while the capsule recorded for 48 hours. However, the 
catheter system recorded almost double the acid exposure time in both groups on 
study subjects. There was correlation between pH values and a concurrence of 
	  diagnostic yield of 82.1%. Even with such positive results scientists feel that the two 
methods cannot be interchanged. (45) 
Upper gastrointestinal endoscopy doesn’t hold much use in the diagnosis of 
GERD; however it helps with diagnosing the complications, which arise with GERD, 
such as esophagitis and Barrett’s esophagus. The upper endoscopy is usually utilized 
to place the wireless catheter in case of pH monitoring. Biopsies can be done with the 
help of upper GI endoscopy in order to confirm any adenocarcinoma caused by 
prolonged exposure to acidic reflux. (26) 
Johnston et al conducted a study comparing barium esophagram to esophageal 
pH monitoring and assessed the accuracy of the barium screening as a predictor of the 
acid exposure. The sensitivity and specificity of barium radiography for acid reflux 
and its degrees were insufficient and the test is no longer recommended for the 
diagnosis of GERD. (47) However, this method of diagnosis is used for evaluation of 
complications related to GERD as well as evaluation of dysphagia in the post anti-
reflux surgery patients. (26) 
Diabetes Mellitus 
Diabetes mellitus has become a world renowned and dreaded disease. However, 
throughout the world its origin varies but from South East Asia and more specifically 
India diabetes mellitus has had its roots dating to the ages of the Gods. It has been told 
through many historical stories that lord Ganesha had “prameha”, Pra denoting excess 
	  and meha referring to urine.  This was the ancient terminology used for diabetes 
mellitus. To this why we would philosophically connect diabetes with lord Ganesh is 
for a very obvious reason, his love for sweets and his sedentary life style.  
Indian medicine was so advanced in the 10th century BC that it distinguished 
two types of diabetes mellitus. Later diabetes was termed “madhumeha” madhu 
meaning honey and meha again meaning urine. The two variants were krisha (lean) 
denoting type 1 diabetes mellitus and sthula (obese) denoting type II diabetes. This is 
the remarkable origin of diabetes from India.  
Diabetes Mellitus on Gastrointestinal Tract 
 When we look more specifically at how diabetes affects the gastrointestinal 
tract we can come to understand the side effects of gastro esophageal reflux disease in 
relation to diabetes. Hopefully, getting ample insight into how much involvement the 
gastrointestinal system has with hyperglycemia. It is a known concept that after the 
intake of food the postprandial blood glucose rises. Therefore it is by means of the 
gastrointestinal tract that the absorption of nutrients influences the blood glucose.  
Acharya et al confidently states that the prevalence of various upper 
gastrointestinal symptoms occur more frequently in diabetic patients with relation to 
their hyperglycemic control. When we want to scrutinize more into the various effects 
of diabetes mellitus on the gastrointestinal tract we can start with its effects on the 
esophagus, stomach, small intestine, large intestine, liver, gall bladder, and pancreas. 
	  In the esophagus, esophageal motility disorders and esophageal reflux disease are well 
known conditions. When we enter the stomach there lays impaired gastric emptying, 
gastro paresis and diabetic dyspepsia. Small and large intestine effects vary from 
diarrhea to constipation and fecal incontinence in the anorectal region. Since the liver, 
gallbladder and pancreas are part of the gastrointestinal system, we can briefly look 
into the effects caused to those organs. Non-alcoholic fatty liver disease, 
hepatocellular carcinoma, gallstone formation, cholecystoparesis and finally 
emphysematous gallbladder may be the effects of diabetes mellitus.  
It has been documented that gastrointestinal symptoms such as nausea, 
heartburn, vomiting, are more common in those with diabetes. The upper 
gastrointestinal symptoms are believed to be caused by autonomic neuropathy and or 
hyperglycemia. The neuroendocrine system of the gut gives out peptides and various 
amines, which show its effect on gastrointestinal motility. These are the frontrunners 
for gastrointestinal complications and the appearance of symptoms. Due to all these 
effects and complications being so common, a term such as diabetic enteropathy was 
coined to cover all effects on the gastrointestinal system.  
In 1937, Ferroir et al reported that in those diagnosed with diabetes mellitus the 
contractions within the stomach were slow and the contractions were due to lack of 
vigor which would die out quickly. The culprit being hyperglycemia was proved by 
all symptoms being alleviated by administration of insulin. Insulin was found to 
resolve the secretory and motor abnormalities. There was no correlation between the 
	  duration of the disease and the onset of symptoms, and that it showed its effect on 
both type I and type II diabetes patients. (4) 
Now there comes shift of focus from the effect of diabetes in general to 
specifically the esophagus and the structures within it. The basics lie in esophageal 
motility and sphincter control by the nervous system. At first the gastrointestinal 
symptoms were accredited to irreversible autonomic neuropathy however now there 
lies a change in concept and the thinking is that they are acute changes in blood 
glucose concentration, which affect the gastrointestinal motor function, which lead to 
these symptoms. It is believed those autonomic neuropathy and glycemic controls, 
which are closely related to the pathogenic effect of symptoms.  
Animal studies showed morphological changes in the autonomic nerves, which 
supplied the gut, which included decrease in the number of myelinated axons, 
reduction in neurotransmitters, and deficiency in the interstitial cells of Cajal.  In 
rodent studies, which were conducted, rodents with diabetes had a reduced amount of 
nitric oxide (NO) synthase expression within the myentric neurons. This was 
associated with slower gastric emptying. However this doesn’t hold true for humans 
as nitric oxide accelerate gastric emptying. Therefore we cannot hold true the entire 
animal model in relation to humans. Stunkard et al proved that with IV infusion of 
glucose, solid and liquid gastric emptying rates are slower in elevated blood glucose 
levels compared to a euglycaemic state. This proves that hyperglycemia has effects 
throughout the entire gut and not only on particular portions. In a population based 
	  study asking about gastrointestinal symptoms in diabetes vs controls with 423 diabetic 
patients and 8185 controls the diabetic patients showed more symptoms of 
gastrointestinal tract. The reason for these symptoms in diabetics are due to many 
reasons, ranging from, disordered motility, autonomic neuropathy, visceral 
hypersensitivity, changes in gastrointestinal myoelectrical activity, use of medications 
and psychological distress. Visceral hypersensitivity plays a role in which, patients 
with symptoms show acute changes in blood glucose thereby affecting the perception 
of sensations arising from the gut. However due to this untouched aspect, the 
mechanism behind why blood glucose concentration affects gut function remains 
unknown. In many studies the evaluation of contractile activity of the esophageal 
body and lower esophageal sphincter is by means of manometry, esophageal pH 
recording and endoscopy. Manometric studies in these conditions ideally show 
increased number of abnormal pressure waves and a reduced lower esophageal 
sphincter pressure. (48) A study conducted by de Boer et al found that in induced 
hyperglycemia decrease in lower esophageal sphincter pressure and decrease in 
velocity of the esophageal peristaltic wave was found to be associated. (49) However 
there are no studies to evaluate the effect of altering blood glucose levels on the 
esophageal motility in diabetics. (48) It is stated in textbooks that the presence of 
gastro-esophageal disease is increased in those with diabetes as a result of delayed 
emptying from the proximal stomach. It is also stated that the prevalence of 
esophagitis has not been formally evaluated. (48) 
	  Delayed gastric emptying leads to esophagitis as mentioned before and this 
may be due to lax lower esophageal sphincter leading to the exposure of the 
epithelium to acidic content. The earliest documented study was done in 1945 by 
Rundles et al who found that out of 35 diabetics 5 of them had delayed gastric 
emptying with clinical evidence of peripheral neuropathy. (50) Along with all these 
data there lays a controversy that could the development of diabetes be due to the 
delayed gastric emptying, which causes higher postprandial blood glucose 
concentrations. (48) There are many controversies discussed in this area with regard to 
diminished gastric acid secretion as an outcome of autoimmune gastritis and atrophy.  
Along with the above mentioned, there may be associated pernicious anemia where 
due to vitamin B 12 deficiency peripheral neuropathy may arise. In such situations 
how can one differentiate this peripheral neuropathy from that of diabetic neuropathy. 
This is supported by the fact that presence of peptic ulcers and gastric acid secretory 
disease appear to be less in diabetics. (48) Horowitz and Dent et al conducted a 
manometric study with recordings of pressures in the antrum, pylorus and duodenum 
were taken after the intake of a solid meal, in a normal volunteer the number of antral 
contractions were normal however in the diabetic there was hypo motility in 87 with 
blood glucose concentration of 14mmol/L. (48) Through this manometric study it 
becomes evident that the antral waves are reduced in number which in turn is 
temporarily associated with duodenal waves. All these factors contribute to the 
delayed gastric emptying. 
	  Along with the membranes of the smooth muscle fiber present within the wall 
of the gut there is a continual slow intrinsic electrical activity. There are two types of 
electrical waves, slow waves and spikes. The resting membrane potential of the 
gastrointestinal tract is not constant even under normal conditions. One may quote 
according to the textbook value that the resting membrane potential of the 
gastrointestinal tract is about an average of -56 mV; however multiple minute changes 
can disrupt this value.  
These electrical changes are what control the motor activity of the 
gastrointestinal tract. The above-mentioned slow waves show rhythmic changes and 
not proper action potentials. The slow waves are graphical representations of 
undulated changes, which occur, in the resting membrane potential. As mentioned 
previously there is no such constant resting membrane potential in the smooth 
muscles of the gastrointestinal tract. The intensity varies from 5 to 15 mV and the 
frequency changes in accord to the location of the concerned part of the 
gastrointestinal tract. It is believed that in the smooth muscle the slow waves are 
caused by the interaction between the smooth muscle cells and a specialized cell 
known as the interstitial cells of Cajal, which was mentioned previously. These cells 
are also known more commonly as electrical pacemaker cells of smooth muscles. 
These specialized cells form a network with one another and are placed between 
smooth muscle layers, with synaptic like contacts to the smooth muscle cells.  
	  These cells undergo cyclic changes in membrane potential due to ion channels 
which open passing pacemaker currents, which lead to slow wave activity, this occurs 
periodically. The second type of wave pattern is a spike potential. These spike 
potentials are proper action potentials which make the resting membrane potential 
more positive. The higher the slow wave potential increases the more spike potentials 
are likely to get generated. The frequency varies from 1-10 spikes in one second. 
These spike potentials, which are generated, are due to large amounts of calcium 
entering with small amounts of sodium ions entering. The depolarization of the 
membrane causes the stretching of the muscle and this stimulation is caused by 
acetylcholine, which is released from the parasympathetic nerves. Stimulation of 
sympathetic nerves on the other hand causes hyper polarization.  
Along with all these events taking place the gastrointestinal tract has a mini 
brain or the enteric nervous system. This enteric nervous system contains somewhere 
around 100 million neurons. This system is essential in controlling gastrointestinal 
movements and to a lesser extent secretions. There lies presence of two plexus of 
nerves, the outer plexus, myenteric plexus or commonly known as Auerbach’s plexus 
and the inner plexus, or sub mucosal/ Meissner’s plexus. The myenteric plexus gives 
rise to gastrointestinal movements where as the Meissner’s plexus controls the 
gastrointestinal secretions. The sympathetic and parasympathetic fibers connect to 
both myenteric and submucosal plexuses. With the addition of the sympathetic and 
	  parasympathetic systems the gastrointestinal functions are greatly influenced, 
compared to when they are innervated alone by the enteric nervous system. (10) 
The cranial parasympathetic fibers are most commonly recognized as the vagus 
nerve, which innervates a majority of the gastrointestinal tract. These fibers 
extensively innervate the esophagus, stomach and pancreas. (10) Heatley et al 
comments that several of the physiological abnormalities that are associated with 
gastro esophageal reflux are similar to those which are found after surgical truncal 
vagotomy. Some of these features are due to the rise in lower esophageal sphincter 
pressure and increased abdominal pressure, which is decreased in patients with gastro 
esophageal reflux disease, similar to that of what, appears after surgical vagotomy.  
Another feature is due to delayed gastric emptying as gastric stasis occurs after 
a truncal vagotomy. Heatley et al goes further in stating that vagal impairment caused 
by diabetic autonomic neuropathy is seen as a decrease in lower esophageal sphincter 
pressure and could give rise to gastro esophageal reflux. In a study conducted with 34 
patients the vagal function was tested in patients suffering from gastro esophageal 
reflux by measuring the gastric secretory response to insulin induced hypoglycemia. 
Manometry showed that the LES pressure ranged from 0-26 mmHg. One finding in 
this study was that the loss of vagal function favors gastric stasis, and the presence of 
large amounts of irritant substances in the stomach leads to gastro esophageal reflux 
and esophagitis. (50) 
	  In another study conducted in Konkuk South Korea, 190 diabetics and 190 
controls were enrolled. 137 out of the 190 diabetics and 116 of the 190 controls had 
gastrointestinal symptoms. Kim et al expresses with concern about the prevalence of 
diabetes worldwide and more specifically in South Korea, moving into becoming an 
epidemic. The effects of diabetes are numerous, like obesity and the sedentary 
lifestyle take quite a toll on the human body. The need for this study having to be 
conducted in various regions giving rise to their own values and standards and its 
importance is discussed. Due to variation in ethnicity and race all over the world 
diabetes affects each ethnic group in different ways; therefore a generalization cannot 
be made. Therefore the need for such population studies holds considerable value. It 
has been proved that diabetes mellitus affects various regions of the gastrointestinal 
tract, depending upon the region and the presence of various symptoms. Many 
pathogenic mechanisms may be suggested in its etiology however controversy always 
revolves around those mechanisms. To name a few mechanisms some like autonomic 
neuropathy, diabetic peripheral neuropathy, glucose imbalance, diabetic duration and 
psychiatric disorders exist. The above study was conducted in an attempt to identify 
the frequency of gastrointestinal symptoms in the subjects and to unravel its etiology.   
This study was in so much detail that the diabetic complications, which the 
patients were having, were specifically and individually investigated. Those who had 
diabetic nephropathy were classified into this complication after defining it as 
prominent proteinuria upon urine analysis or serum creatinine, which exceeded 
	  133µmol/L. With the assistance of nerve conduction studies peripheral neuropathy 
was assessed. Diabetic retinopathy was diagnosed based on fundoscopic examination 
by trained ophthalmologists. The patient’s HbA1c was also measured by means of 
high performance liquid chromatography. The patients’ administration of oral 
hypoglycemic drugs and insulin was also documented.   
After statistical analysis was performed the results indicated the following 
findings. The frequency of the gastrointestinal symptoms in diabetic patients was 72% 
where as in the controls was only 62%. After multiple logistic regression analysis 
being done the results showed that the diabetics presented with a much higher 
frequency of upper gastrointestinal symptoms rather than the controls. To one’s 
surprise there was no difference in the lower gastrointestinal symptoms between the 
two studied groups. Among the various upper gastrointestinal symptoms offered to 
the individuals in the questionnaire the results showed that globus, heartburn and 
dysmotility like dyspepsia were more frequent among the diabetics in comparison to 
the controls. Another astounding finding was that among those diabetics with upper 
gastrointestinal symptoms, there was presence of more complications with elevated 
HbA1c, with those who had symptoms for a longer duration. There showed 
prevalence in upper gastrointestinal symptoms in subjects with an HbA1c between 
8%-9%.  
With all these statistical factors being so evident the presence of chronic 
gastrointestinal symptoms represents a clinically important problem in a large group 
	  of diabetics around the world. The risk of only upper gastrointestinal symptoms in the 
diabetic group showed statistically significant increase. Very commonly 
gastrointestinal symptoms in diabetics have been recognized to be motor dysfunction 
which may be due to irreversible autonomic neuropathy accordingly to the above 
study.  
Kim et al observed that acute changes in blood glucose concentration to alter 
or reduce the autonomic nerve function. Since this study gave much importance and 
insight into the various levels of HbA1c in relation to upper gastrointestinal symptoms 
it is well recommended that in order to avoid serious complications it remains safe to 
maintain the HbA1c of the diabetic patient below 8%. They finally go forward to state 
that chronic upper gastrointestinal symptoms can be reversible with a cautious control 
of blood glucose level. (51) 
In most of the above-mentioned studies conducted a term referred to as 
autonomic neuropathy keeps coming up repetitively. In order to completely 
understand the entire effect of autonomic neuropathy one needs to completely look 
into its theory. Autonomic neuropathy is a generally coined term, which can virtually 
affect any type of autonomic function in a diabetic. Due to its cunning nature of being 
insidious in onset and involving multiple organs diabetic autonomic neuropathy 
becomes at times even unrecognizable to the physician. In contrast, when it affects 
one particular organ alone the patient is subjected to a battery of tests only to 
misdiagnose the underlying medical condition. They go further to state and claim that 
	  like other various forms of diabetic neuropathy, diabetic autonomic neuropathy is 
diagnosed by means of exclusion.  
The autonomic control for each organ is divided into opposing sympathetic and 
parasympathetic divisions. These nerve fibers that belong to the autonomic nervous 
system are anatomically dispersed in a web like pattern making it not easily accessible 
for study. Even with this natural difficulty, scientists over the past few decades 
devised many ways to study the autonomic nervous system especially in diabetics. 
These studies were conducted organ wise making diagnosis and confirmation 
definitive and easy.  
As mentioned previously the gastrointestinal autonomic neuropathy can occur 
almost anywhere along its entire 15-foot course. However, what remains somewhat a 
mystery is that asymptomatic esophageal motility disorders are common in long 
standing diabetes rather than in heartburn and retrosternal discomfort. 
As stated by Clarke et al in 1979 diabetic autonomic neuropathy may cause 
acid secretory and motility disorders. This type of gastropathy has also shown a 
reduction in frequency of duodenal ulceration in diabetics. (52) 
The frequency of gastrointestinal symptoms as mentioned has been proven to 
be higher in those with diabetes mellitus. However, these symptoms have shown that 
they can influence the health quality of life, thereby influencing productivity and 
employment status.  
	  Wang et al remarks that up to 75% of diabetic outpatients referred to tertiary 
care centers came with gastrointestinal complaints.  
Bytzer et al suggest that the rise of gastrointestinal symptoms may be due to 
neuropathies and majority of these gastrointestinal symptoms are poorly related to 
neuropathy caused by diabetes but due to psychiatric illness. However, studies remain 
consistent in the duration of diabetes and its association with those symptoms. This 
study took into account the relationship between duration of diabetes, HbA1c, BMI, 
diabetic neuropathy and its existence with GERD symptoms most frequently 
heartburn and regurgitation. They focused on the role of diabetic neuropathy in the 
development of symptoms of GERD in type II diabetes mellitus.  
This study consisted of 150 diabetic patients. To ensure maximum specificity 
for analysis of GERD symptoms they took into account only the participants with 
frequent symptoms and excluded patients with less frequent symptoms than weekly 
once. The patients were separated into two groups based on the presence or absence 
of peripheral neuropathy. In a total of the 150 diabetic patients 46 had neuropathy and 
104 didn’t. Peripheral neuropathy was confirmed by past changes in neuropathy, 
positive sensory symptoms which varied from limb numbness, pricking and aching 
pain. They were also subjected to clinical neurological examination where at least one 
sign had to be positive. Either positive monofilament test where there was decreased 
pressure or pain sensation, positive cotton wool test which indicated diminished light 
touch and finally decreased tendon reflexes. In the group studied the duration of 
	  diabetes were 12 ± 9.2 years and the average HbA1c level was 7.7% ±2.0%. All the 
patients included in the study were actively being treated for type II diabetes mellitus 
with 56.6% taking metformin for their control. (38) It was stated in a study that intake 
of metformin gives rise to only lower gastrointestinal symptoms and not upper 
gastrointestinal symptoms. 30 percent of the patients in this study reported the 
presence of heartburn at least once a week and 40 % having symptoms of GERD. 
There seemed to be no difference in age, body weight, BMI or duration between 
patients with neuropathy and those without neuropathy. However the study concluded 
that the prevalence of heartburn, chest pain and chronic cough were found to be 
higher in patients with neuropathy when compared to those without neuropathy. (53) 
Zhang et al conducted a study to observe the effect of hyperglycemia on 
triggering transient lower esophageal sphincter relaxation. As we had seen previously 
about the functional status of what transient lower esophageal sphincter relaxation 
was we learned that it contributes an enormous amount to the prevention of reflux.  
This study was conducted to observe the acute changes in blood glucose levels and its 
effect on the gastrointestinal motor function in normal patients as well as diabetes. 
Marked hyperglycemia affects the motility in all structures of the gastrointestinal tract 
from the esophagus to the anus. In healthy volunteers this acute hyperglycemia 
decreases the basal lower esophageal sphincter pressure. There has been noted an 
increase in the duration of passage and decrease in the velocity of the peristaltic 
	  even within normal postprandial range has shown to slow down gastric emptying 
irrespective of it being solids or liquids. In this article the esophageal function is 
abnormal as a result of irreversible vagal damage. The most important stimulus for 
initiating TLESR is the vagal pathways integrated in the brainstem causing gastric 
distention. By noting the alterations in cardiovascular reflexes and reduction in the 
secretion of pancreatic polypeptide it is noted that hyperglycemia suppresses vagal 
activity. Finally this study was conducted in healthy individuals in order to observe 
the effect of both physiological and marked increase in blood glucose values on 
triggering TLESR. 15 healthy individuals were subjected to pressure controlled 
gastric distention during marked hyperglycemia or volume-controlled distention 
during physiologic hyperglycemia. The controls were euglycemic. Zhang et al found 
that in healthy volunteers marked hyperglycemia doubles the rate of TLESR triggered 
due to gastric distention. This is irrespective of if the stimulus is pressure or volume 
controlled distention. The rate of TLESRs is determined by numerous factors such as, 
food intake, cholecystokinin, sleep and posture. Marked hyperglycemia reduces 
gastric antral motility and amplifies pyloric motility. At the same time there is 
reduction in proximal gastric tone and slowing down of the gastric emptying. Due to 
the presence of CCK there is presence of gallbladder contraction. Hyperglycemia was 
also reported to reduce the basal LES pressure, and due to this the possibility of 
increased reflux episodes occurs.  In this study, this theory was disapproved. What 
this study concluded was that in healthy individuals, marked hyperglycemia and not 
	  physiological hyperglycemia increased the rate of TLESRs. This is however not 
related to the proximal gastric wall tension. (54) 
Promberger et al states the incidence of type II diabetes worldwide in 2010 was 
284.8 million people and a projection of 438.7 million diabetics in the year 2030. She 
also goes to say that 40 percent of the adult population suffers from GERD. 
Therefore, there lies a need to correlate the two medical conditions. Since diabetes 
mellitus has been suggested to be a metabolic syndrome varied with visceral fat 
accumulation, dyslipidemia, hypertension and hyperglycemia correlation with the 
pressures of GERD can be done. Hyperglycemia shows that there will be an increase 
in gastric H+ secretion and as mentioned in previous studies due to increased gall 
bladder contraction there will be higher levels of bile acids, and decreased bicarbonate 
levels. This study also confirms that delayed gastric and esophageal emptying exists 
along with increased rates of TLESRs and reduced LES pressure. This study confirms 
that most studies prove the presence of GERD on the basis of questionnaires, instead 
of using GERD standard testing such as pH monitoring, manometry, upper 
gastrointestinal scopy, and barium studies. This study was particularly carried out to 
investigate GERD specific symptoms in patients with type II diabetes mellitus, using 
standard diagnostic instruments. These results were compared to non-diabetic GERD 
patients to identify the diabetes related differences. All patients were scrutinized by, 
upper gastrointestinal scopy, manometry, barium esophagram and 24 hour pH 
monitoring. During the two-year period 130 non-diabetic GERD patients were 
	  enrolled as the control group. 65 diabetics were enrolled. In relation to GERD 
symptoms, when comparing the two groups no essential differences was noted. 
Diabetics with neuropathia and those without also didn’t differ in the GERD 
symptoms. The duration of diabetics also had no impact on the GERD symptoms. H-
pylori infections upon endoscopy showed a higher prevalence in patients with type II 
diabetes. Manometry revealed a significantly higher median pressure of LES for 
diabetics. In this study the HbA1c levels in diabetics didn’t correlate with LES 
pressures, relaxation time or peristalsis.   
Symptoms, endoscopy, 24-hour pH and manometry parameters in type II 
diabetics were analyzed in accordance with the specific treatment they were receiving 
for type II diabetes mellitus. No difference was found in all parameters between those 
with dietary restrictions alone, with diet and oral hypoglycemic drugs or those who 
were insulin dependent. (55) 
Esophageal manometric and radiographic abnormalities are common in 
patients with diabetes mellitus. Most of these patients may go asymptomatic. The 
pathophysiology of these irregularities are thought to be degenerative effects of 
diabetes due to its effect on the autonomic nervous system, and not the smooth muscle 
dysfunction, this is supported by histological evidence and pharmacological data. In 
initial manometric studies conducted in the late 1960s authors found that there was a 
decrease in amplitude of peristalsis, and decrease in LES pressure in diabetics who 
suffered from autonomic neuropathy. Other later studies helped prove the same 
	  findings in those who had and didn’t have neuropathy. They go further to state that in 
a study of 50 diabetics with and without peripheral neuropathy there was a decrease in 
primary peristalsis which means that there was greater than 10% absence of peristaltic 
response to a swallow taken, an increase in two or more contractions in more than 
25% of the swallows and finally an increase greater than 10 spontaneous contractions 
during a 35 minute study. All these above findings were in the diabetic population 
suffering from neuropathy. There was also a noteworthy decrease in the velocity of 
peristalsis in those with neuropathy. They feel that these variations in the study 
findings may be due to the development of improved manometric equipment over the 
course of 40 years.  
This particular study contained 25 diabetics who were non-insulin dependent 
and 25 healthy control volunteers. The individuals were subjected to an eight lumen 
water perfused catheter with transducers to measure the pressures. The diabetic 
patients were studied four hours after breakfast was taken. The results after analysis 
showed that end inspiratory pressure, mid expiratory pressure and end expiratory 
pressure was similar amongst diabetics and controls. The percentage of relaxations 
was low in diabetics compared to the controls, this helps prove that the lower 
esophageal sphincter pressure is significantly lower thereby leading to poor relaxation 
of the LES in diabetics.  The peristaltic velocity was lower in diabetics at both the 
proximal and distal ends with both wet and dry swallows; therefore it was statistically 
	  significant at the proximal esophagus with dry swallows and distal esophagus with 
wet swallows. (56) 
Abid et al conducted a study with an objective to compare the gastrointestinal 
symptoms in diabetic patients with controls and its relationship with complications of 
the disease, duration and glycemic control. There remains much controversy in this as 
through questionnaires and conducted studies it is proven that the GI symptoms in 
diabetics are significantly increased when compared to non-diabetics. They have 
quoted in this article that a study conducted in a Chinese population showed 
significant correlation between the period of diabetes and the occurrence of 
symptoms. However, the duration of diabetes and the type of treatment was not found 
to be related with the increase in regularity of gastrointestinal symptoms. All these 
studies go back to the basics that the abnormality of the GI motility is a manifestation 
of irreversible autonomic neuropathy. They go further to explain that other vital 
factors such as acute changes in blood glucose, oscillation in insulin levels, poor 
glycemic control and presence of infection of Helicobacter pylori in diabetics should 
be taken into consideration. A total of 514 patients were enrolled in this study, of this 
250 were diabetics and 264 were non-diabetics. They were all subjected to a detailed 
questionnaire with regard to the gastrointestinal symptoms, which they felt over the 
past 12 months. The diabetic complications were also included in the questionnaire to 
determine their presence. The questions for the complications were, “did your doctor 
tell you about kidney damage?” for nephropathy, “Do you suffer from pins and 
	  needles in your hands and feet?” for peripheral neuropathy, and “are you aware of the 
eye damage as a result of your diabetes?” for retinopathy.  Their HbA1c levels were 
also recorded.  
It was observed in this study that there lies an increase in the number of 
symptoms in relation to the severity of poor glycemic control in type II diabetics. 
Based on HbA1c values they have observed that acute or sub-acute changes in the 
glucose concentration are a key factor for increased frequency in symptoms. Their 
findings include that an HbA1c of more than 7 showed a significant rise in upper GI 
symptoms. They go further to hypothesize that this maybe due to the direct effect of 
hyperglycemia on the vagus nerve, which leads to delayed gastric emptying and 
increased relaxation of proximal stomach or the central effect of hyperglycemia on the 
central vagal nuclei. Diabetic autonomic neuropathy is said to be among the slightest 
documented and understood complications of diabetes. There lie multiple reasons for 
diabetic neuropathy, which include metabolic insult to nerve fibers, neurovascular 
insufficiency, autoimmune damage and neuro-hormonal growth factor deficiency. In 
diabetics esophageal dysfunction is due to at least in part from vagal neuropathy and 
delayed gastric emptying largely depend on the function of the vagus nerve. However 
it cannot be concluded that neuropathy alone is responsible for the gastrointestinal 
symptoms perceived by patients. In this study no association was found between the 
duration of diabetes and the gastrointestinal symptoms. Nevertheless, poor glycemic 
control showed significant generation of upper GI symptoms in diabetics. They 
	  conclude by saying that secondary diabetes prevention methods should be sought out 
after to better management of diabetes and bring down the caseload related to 
gastrointestinal symptoms. (57) 
In a community based study conducted in the United States among residents of 
Olmstead county Minnesota, through a questionnaire there was found to be no 
difference in the prevalence of symptoms such as nausea and vomiting, dyspepsia or 
constipation among both type I and II diabetics and controls. (58) In another study 
conducted in the United States, Feldman and Schiller et al found that 76% of patients 
referred to diabetic clinic had at least one gastrointestinal symptom and 60% reported 
constipation. (59) In a study conducted by Clouse and Lustman et al found 20% of 
patients with diabetes mellitus complaining of nausea, abdominal pain and diarrhea, 
with only 12% had constipation. (60) Looking at a study conducted in Germany 
constipation and nausea were the more frequent symptoms in type II diabetic 
individuals presented with. (61) There are many studies conducted in various parts of 
the world contradicting one another’s findings. In a study conducted in Great Britain 
Maxton and Whorewell et al observed the increased presence of constipation however 
only in patients with diabetes mellitus complicated with autonomic neuropathy. (62) 
Although in the previously mentioned above study conducted by Clouse and Lustman 
et al found that the presence of autonomic neuropathy in patients with diabetes 
mellitus was unassociated with the gastrointestinal symptoms. With all these 
controversies in mind, one can wonder if individual’s ethnicity, race, socio-economic 
	  status, lifestyle and region of residence play a role in these symptoms. All the 
previous studies mentioned before conducted within Asia showed much varied 
results, in comparison with the European and American data. (60) 
In order to have a complete understanding we have seen the physiology and 
functional status of the lower esophageal sphincter. However there lays a 
physiological process known as aging, which we need to understand if it affects the 
sphincter control in any way thereby giving hindrance to our study.  Aging has been 
defined as a universal and irreversible degeneration of the human body. (63) Due to this 
process there is a general decline in physiologic function. Special complains with 
regard to the foregut is, regurgitation, heartburn and dysphagia.  In this study 
Gutschow et al says that the degenerating effect of aging on motor function and its 
relation to the esophageal function is not clearly understood. In 1964 a study 
conducted showed age related changes in the contractile amplitude, incomplete 
sphincter relaxation and esophageal dilation. However this study was challenged and 
proven that only minor changes of esophageal motility was present in healthy elderly 
individuals. The ill esophageal motility, which was present, was because of 
underlying causes such as GERD rather than the cause of purely aging. In the study 
conducted by Gutschow a total of 127 women and 199 men were taken into the study 
and subjected to esophageal manometry. In 96% of the subjects upper GI- endoscopy 
was done and in 92% of the subjects 24-hour pH monitoring was performed. For the 
purpose of analysis, patients were divided into 5 groups according their age. 17-39 
	  group 1, 40-49 group 2, 50-59 group 3, 60-69 group 4 and above 70 for group 5. They 
found that there was no significant difference between the 5 different groups for 
males and females. GERD was equally found to be distributed among all age groups. 
There was no difference between any of the groups for both resting pressure and 
length of LES. No correlation with age for both parameters among GERD and non 
GERD patients. In GERD patients, there was a significantly lower resting LES 
pressure than non – GERD patients, this didn’t hold true for the length of the LES. (64) 
There are studies conducted to see the influence of sex and gender on 
gastroesophageal reflux disease. GERD has been classified as either being Non-
erosive reflux disease or reflux esophagitis.  It was found that Non-erosive reflux 
disease (NERD) affects women more than men. GERD symptoms were found more 
frequently in patients who suffered from the Non-erosive reflux type rather than the 
erosive type, making women more symptomatic. However it was found that men were 
affected more by carcinomatous lesions such as Barrett’s esophagus and esophageal 
adenocarcinoma. With an increasing age above 50, women started to show more 
incidences in the complications of reflux esophagitis. What protected women till the 
age of 50, was it due to the anti-inflammatory action of estrogen, a hormone which is 
prevalent in women.  This hormone could protect the esophageal epithelium against 
refluxate due to its anti inflammatory action. (64) Hence, many factors like sex, age, 
diabetes play a role in the pathogenesis of GERD.  
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  MATERIALS AND METHODOLOGY: 
The study was conducted in the Gastrointestinal Motility Laboratory in the 
Department of Gastroenterology, PSG IMS&R, after getting clearance from the 
Institutional Human Ethics Committee (IHEC). Informed and written consent was 
obtained from all those who participated before initiation of the study.  
Thirty-five type II diabetes mellitus patients and thirty-five non-diabetic 
patients presenting with upper GI symptoms were included in this study. Patients with 
type II diabetes presenting with upper GI symptoms constituted the study group. Non-
diabetes patients presenting with upper GI symptoms were labeled to be in the control 
group. Both these groups were subjected to High Resolution Esophageal Manometry. 
A case group of 35 diabetics who presented with heartburn and were referred 
for high-resolution manometry were included in the study. During the duration of 
one-year study period all diabetics who presented with heartburn and were asked to 
undergo high-resolution manometry and fell into the inclusion criteria were included 
in this study.  
The control group was age matched with non-diabetic patients who presented with 
heartburn and were referred to undergo high-resolution manometry.  
INCLUSION CRITERIA: 
STUDY GROUP: 35 Type II Diabetes Mellitus patients presenting with heart burn. 
 
	  EXCLUSION CRITERIA  
1. Pregnancy 
2. Alcoholics 
3. Type I Diabetes  
4. Gestational Diabetes 
5. Carcinoma of Upper GI tract 
6. Upper GI motility disorders 
7. On drugs which alter the sphincter tone by acting on the smooth circular 
muscles of the LES  
 
 
a. β agaonists 
b. α adrenergic agonists 
c. Nitrates 
d. Ca2+ channel blockers 
e. Anticholinergics 
f. Theophylline 
g. Morphine 
h. Meperidine 
i. Diazepam 
j. Barbituates 
	  All those who were referred for esophageal manometry testing by the 
gastrointestinal consultant or surgical consultant and who were sent to the GI motility 
lab and fit the criteria were subjected to this study.  
Those who had type II diabetes and non-diabetics with upper gastrointestinal 
symptoms who presented with heartburn were separated into the study and control 
groups by the principal investigator respectively.  
Both the control and study group were subjected to high-resolution manometry 
after explanation of the procedure.  
A thorough history was taken from the patient by the investigator and cross 
referenced with the existing history present in the patient’s file.  In case of type II 
diabetic patients with upper gastrointestinal symptoms, HbA1c was noted in order to 
find out their glycemic control. The patient was explained about the procedure in 
detail, its advantages, and explained about the discomfort they may feel. After noting 
down their name, age, sex and relevant history in the record, they were shown the 
equipment that was going to be used and explained about the procedure. The catheter, 
which is to be inserted, was shown to the patient and explained about its flexibility 
and due to its flexibility their cooperation is essential during its insertion.  
 
 
 
	  ESOPHAGEAL MANOMETRY: 
 The patient was asked to come for the testing with overnight fasting and 
nothing taken orally till the procedure was complete. They were also instructed to stop 
taking proton pump inhibitors, if they were taking it, 7 days prior to the procedure.  
 The patient was asked to lie flat in supine position and after application of 
lignocaine gel on the probe for anesthetic and lubricative purpose the probe was 
inserted into the esophagus by way of the nasal cavity. Before the insertion was done, 
the patient’s nasal cavity was examined with the help of sufficient light to rule out any 
nasal deviation or polyp, which could obstruct the entry of the catheter. Once all these 
factors were ruled out the patient was asked to swallow the tube, like swallowing 
saliva. The tube was easily passed into the esophagus, due to its small size and 
flexibility. The disadvantage was the size and flexibility of the tube, which cannot be 
forced in to the cavity, and therefore complete cooperation from the patient and 
patience from the person doing the procedure was essential.  
Fig 7, the below picture depicts insertion of the catheter through the nasal 
cavity, pharynx via the esophagus to the stomach.  
 
 
 
	  Fig 7  
 
 
 
 
The physiologist monitored the probes entry into the lower esophageal 
sphincter by observing the pressure changes; which was plotted initially on a line plot 
and then converted to a color graph on the screen. Once the lower esophageal 
sphincter was identified the probes were fixed. The lower esophageal sphincter was 
identified by an increase in pressure in that area, which is depicted by a change in 
color on the color plot.  
Fig 8, below picture depicts how the UES and the LES will appear on a color 
plot in the screen during manometry.  
    Fig 8 
 
 
 
	  A basal reading was taken for about one minute. Then the patient was given 
about 5-7 ml of water, which they were asked to swallow slowly. In-between the 
swallow of water saliva was not to be swallowed and this was clearly instructed to the 
patient. Between each swallow 30 seconds of recording was done. The patient was 
made to swallow 10 times and the recording was made between two swallows. After 
this, the probe was removed from the esophagus.  After a small break, the patient was 
asked to come back for the insertion of pH monitor if needed or prescribed by the 
consultant. 
Fig 9, the picture below shows a normal manometry recording  
Fig 9 
 
 
 
	  The following parameters were noted for both the groups during high resolution 
manometry: 
1. Basal Lower esophageal sphincter pressure 
2. The Basal expiratory pressure  
3. EGJ- CI 
4. Median Integrated Relaxation Pressure 
5. Body Motility 
The results of both the groups were subjected to statistical analysis and significance 
determined. 
Statistical Analysis: 
 In a study group of 35 diabetics and 35 non – diabetics over a duration of one 
year study period data was collected and analyzed. SPSS software version 19, 
Chicago. Illinois was used for statistical analysis of the values obtained.  
 Continuous variables were presented as Mean ± Standard Deviation (SD) and 
categorical variables were presented as absolute numbers or percentages. The 
comparison of normally distributed variables between the control non diabetic group 
and the diabetic case group was performed using Unpaired Student’s ‘t’ Test. 
Nominal categorical data was compared using Pearson Chi- Square Test.  
 For the following values Mann Whitney test, a non-parametric test was applied 
to gain more significance. The parameters of mean basal expiratory pressure, EGJ-CI 
	  and median IRP in comparison to males and females in both groups, HbA1c in 
diabetics whose values fell above and below 6.5 were compared each of the above 
parameters. The same parameters were checked for the duration of diabetes in two 
groups divided below duration of 5 years and above 5 years.  
For all the statistical tests, p values: 
p > 0.05 was considered statistically insignificant. 
p < 0.05 was considered statistically significant. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   
 
 
 
 
 
 
Results 
	  	  
	  OBSERVATIONS AND RESULTS: 
COMPARISON BETWEEN NON-DIABETICS AND DIABETICS WHO 
PRESENTED WITH HEARTBURN. 
 In this study 70 subjects were included out of which 35 were non-diabetics 
who presented with heartburn to the gastroenterology outpatient department and 35 
diabetics with the same complaints. The study was conducted for a period of one year 
from September 2016.  
 Members of both groups were subjected to esophageal high-resolution 
manometry from which results were obtained. These parameters, which were 
measured, were compared between the control and study groups.  
Table 1(Chart 1): Mean age of Non diabetics and Diabetics  
35 controls and 35 diabetics were part of this study. The age of the 35 controls had a 
mean and SD of 51.23± 10.393 years. The diabetics in the study group had a mean 
and SD of 54.23± 11.330 years and the difference was found to have a p value of 
0.252, which is statistically not significant. This shows that the age of both the groups 
is matched in our study.  
Table 2 (Chart 2): Comparison of sex in the Non-diabetic and Diabetic groups 
The distribution of sex in the control group was as follows, there were 11 females 
(31.4%) and 24 males (68.6%) in the non-diabetic group and 14 females (40.0%) and 
	  21 males (60.0%) in the diabetic study group. After analysis through Pearson Chi-
Square test significance was found to be .454, which is statistically not significant.  
Table 3: Basal Lower esophageal Sphincter Pressure 
The Basal Lower Esophageal Sphincter Pressure is categorized into normal which 
falls in a range of 10-35 mm of Hg, elevated when the value goes above 35 mm of Hg 
and reduced when the value falls below 10 mm of Hg.  The numbers for this is as 
follows: Normal count in control group was 25 (71.4%) and case group was 26 
(74.3%) having a total number of 51 members. In the elevated category in the control 
group was 2 (5.7%) and case group was 3 (8.6%) bringing the total to a number of 5 
members. Finally in the reduced category a count of 8 (22.9%) in the control group 
and 6 (17.1%) in the case group bringing the total to a value of 14 members. Upon 
performing Pearson Chi-Square test significance value of .777 (not significant) was 
obtained.  
Table 4 (Chart 3): Body Motility  
The esophageal body motility is classified as being either propagative or ineffective. 
The two study groups were categorized into either of the following according to their 
motility manometry reports. A total of 62 of the 70 individuals had propagative type 
of motility of this 31 were in the control group and 31 were in the case group. 8 out of 
the 70 had ineffective motility and this was also evenly distributed as 4 in each group. 
There was no significance found in this comparison (p value 1.000).  
	  Table 5: Mean Basal Inspiratory Pressure  
The Mean Basal Inspiratory Pressures which were measured for the control group had 
a mean and SD of 28.246 ± 11.362 and diabetic group a mean and SD of 22.627 ± 
9.125. This shows that in the diabetic group the value was decreased when compared 
to the control group. These values had a p value of 0.026, which was found to be 
statistically significant.  
Table 6 and 7 (Chart 4): Mean Basal Expiratory Pressure  
The Mean Basal Expiratory Pressure recorded during manometry for the control 
group of 35 members in number, had a mean and SD of 17.617 ± 9.17. In the diabetic 
group consisting of 35 members the mean basal expiratory pressure was found to have 
a mean and SD of 23.514 ± 9.66. P value was found to be statistically significant with 
a value of 0.011. There shows an increase in the mean basal expiratory pressure in the 
diabetic group when compared to the control group. When application of Mann 
Whitney test was performed a p value of 0.005 was obtained showing statistical 
significance.  
Table 8 and 9 (Chart 5): EGJ-CI 
The Esophageal-Gastric Junction Clearance recorded for the control group of 35 
members was a mean and SD of 29.920 ± 19.001. In the diabetic group the EGJ-CI 
was found to be a mean and SD of 31.68 ± 13.635. There was an increase in the EGJ-
CI value in the study group when compared to the control group. Upon performing 
	  independent t test for both these groups the p value was found to be .657, which 
shows there was no statistical significance. Upon performing Mann Whitney test for 
the above parameter a p value of 0.229 was it was not statistically significant.  
Table 10 and 11(Chart 6): Median Integrated Relaxation Pressure 
The Median Integrated Relaxation Pressure for the control group’s mean and SD was 
found to be 7.877 ± 5.886. The study group of 35 diabetic patients had a mean and SD 
of 6.337 ± 5.147. There was a slight decrease in the median IRP value in the diabetic 
group. Upon performing independent t test it found that the p value for this was 0.248, 
which showed no statistical significance. Upon performing Mann Whitney test for the 
above parameter a significance of 0.288 was found proving no statistical significance.  
Table 12 and 13 (Chart 7, 8, 9): Comparison of Manometric Parameters between 
Males and Females in the Non Diabetic (Control) Group 
The mean basal expiratory pressure in the 24 males present in the control group had a 
mean and SD of 15.658 ± 6.372. The Females 11 in number had a mean and SD of 
21.891 ±12.766. There was an increase in this value for the females when compared 
to the males. Upon performing independent t test for the above data the p value was 
found to be 0.061, which is not statistically significant.  For the same group the EGJ-
CI showed a mean and SD values of 27.597 ± 14.361 for males and for females mean 
and SD values of 35.027 ± 26.672 showing an increased value for females. Upon 
performing independent t test for the above values the p value was found to be 0.288. 
	  Finally for the same group of males and females the mean and SD of median IRP was 
found to be 8.883 ± 5.440 for males and 5.682 ± 6.275 in females. There was an 
increase in the median IRP value for males when compared to females. Upon 
performing independent t test for the above values the p value was found to be 0.137. 
For all the above data the p values showed no statistical significance. For the same 
parameters comparison was done using Mann Whitney test to find significance. The 
mean rank for males and females for all three parameters were analyzed and found to 
be as follows. Mean rank for males was 16.54 and 21.18 in females for the parameter 
of mean expiratory pressure. The p value was found to be 0.224, which was 
statistically not significant. Mean rank for EGJ-CI for males was 18.13 in males and 
17.73 in females with a p value of 0.930, this also not being statistically significant. 
Finally the mean rank for the parameter IRP was done and found to be 20.52 in males 
and 12.50 in females with a p value of 0.030 showing statistical significance. 
Table 14 and 15 (Chart 10, 11, 12): Comparison of Manometric Parameters 
between Males and Females in the Diabetic (Case) Group 
The mean basal expiratory pressure in the 21 males present in the case group had a 
mean and SD of 24.995 ± 11.022. The females 14 in number had a mean and SD of 
21.293 ± 6.293. This value was slightly increased in males. Upon performing 
independent t test for the above data the p value was found to be 0.273, which is not 
statistically significant.  For the same group the EGJ-CI was seen holding mean and 
SD values of 29.833 ± 13.910 for males and for females mean and SD values of 
	  34.464 ± 13.218, being increased in the female group. Upon performing independent t 
test for the above values the p value was found to be 0.332. Finally for the same group 
of males and females the mean and SD of Median IRP was found to be 6.648 ± 4.960 
for males and 5.871 ± 5.572 in females. Upon performing independent t test for the 
above values the p value was found to be 0.669. For all the above data the p values 
showed no statistical significance. For the same parameters comparison was done 
using Mann Whitney test to find significance. The mean rank for males and females 
for all three parameters were analyzed and found to be as follows. Mean rank for 
males was 19.33 and 16.00 in females for the parameter of mean expiratory pressure. 
The p value was found to be 0.359, which was statistically not significant. Mean rank 
for EGJ-Cl for males was 16.69 in males and 19.96 in females with a p value of 
0.359, this also not being statistically significant. Finally the mean rank for the 
parameter for IRP was done and found to be 19.50 in males and 15.75 in females with 
a p value of 0.293 showing no statistical significance.  
Table 16 and 17 (Chart 13, 14, 15): Comparison of Manometric Parameters 
between those with HbA1c Values <6.5 (Group A)and≥6.5 
The two groups, which were compared in this table, were those within the case 
(diabetic) group whose HbA1c values were < 6.5 and≥ 6.5. The mean basal 
expiratory pressure in the 6 individuals with HbA1c value <6 had a mean and SD of 
25.900 ± 12.403. The remaining 29 individuals who belonged to the group of 
uncontrolled diabetes with HbA1c values ≥ 6.5 had a mean and SD of 23.021± 9.181. 
	  Upon performing independent t test in the above data the p value was found to be 
0.514which is not statistically significant, the individuals who were under control had 
a high sphincter pressure when compared to the uncontrolled group.  For the same 
group the EGJ-CI was seen holding mean and SD values of 22.300 ± 11.530 and for 
the second uncontrolled group mean and SD values of 33.628 ± 13.388.  Upon 
performing independent t test for the above values the p value was found to be 0.063 
(statistically not significant). Finally for the same group of controlled and 
uncontrolled HbA1c levels the mean and SD of Median IRP was found to be 3.700 ± 
2.480for the first group and 6.883 ± 5.410 in the second group. Upon performing 
independent t test for the above values the p value was found to be 0.171. For all the 
above data the p values showed no statistical significance. For the same parameters 
comparison was done using Mann Whitney test to find significance. The mean rank 
for the first group and second group for all three parameters were analyzed and found 
to be as follows. Mean rank for group A was 20.50 and 17.48 in the uncontrolled 
group for the parameter of mean expiratory pressure. The p value was found to be 
0.535, which was statistically not significant. Mean rank for EGJ-CI for group A was 
10.50 and 19.55 in the uncontrolled group with a p value of 0.050, giving a 
statistically significant value. Finally the mean rank for the parameter for median IRP 
was done and found to be 12.33 in group A and 19.17 in the uncontrolled group with 
a p value of 0.146 showing no statistical significance.  
	  Table 18 and 19 (Chart 16, 17, 18): Comparison of Manometric Parameters 
between Diabetics whose duration of the disease is <5 years (Group A) and ≥  5 
years (Group B) 
The two groups which were compared in this table were those within the case 
(diabetic) group whose duration of diabetes was categorized into being < 5 years 
(Group A) and ≥ 5 years (Group B). The mean basal expiratory pressure in the 9 
individuals who belonged to Group A had a mean and SD of 17.889 ± 5.372. The 
remaining 26 individuals who belonged to the group B had a mean and SD of 25.462 
± 10.112. Those who had diabetes for a longer duration had a increased pressure value 
when compared to the ones who had diabetes for less than 5 years. Upon performing 
independent t test in the above data the p value was found to be 0.041, which was 
statistically significant.  For the same Group A the EGJ-CI had a mean and SD values 
of 34.733 ± 12.025 and for Group B the mean and SD values were 30.631 ± 14.215.  
Upon performing independent t test for the above values the p value was found to be 
0.445 (statistically not significant). Finally for Group A mean and SD of Median IRP 
was found to be 6.589 ± 6.827 and for group B 6.250 ± 4.592. Upon performing 
independent t test for the above values the p value was found to be 0.868. For the 
above data the p values showed no statistical significance. For the same parameters 
comparison was done using Mann Whitney test to find significance. The mean rank 
for the first group and second group for all three parameters were analyzed and found 
to be as follows. Mean rank for Group A was 11.67 and 20.19 for Group B for the 
	  parameter of mean expiratory pressure. The p value was found to be 0.031, which was 
statistically significant. Mean rank for EGJ-CI for group A was 20.33 and 17.19 in 
Group B with a p value of 0.446, giving a statistically non-significant value. Finally 
the mean rank for the parameter median IRP was done and found to be 17.61 in-group 
A and 18.13 in the group B with a p value of 0.897 showing no statistical 
significance.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Tables 
	  	  	  
 
	     TABLE 1 
         Comparison of mean age of Non-diabetic and Diabetic group 
 
 
    *P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
 
Non-diabetic group (n = 35) Diabetic group (n = 35) 
 
P value 
Age (in years) Age (in years) 
Mean ± SD Range Mean ± SD Range 
51.23 ± 10.393 37-76 54.23 ± 11.330 33 - 74 0.252 
	  TABLE 2 
 
         Comparison of distribution of sex between Non-diabetic and Diabetic group 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
 
 
   Group 
P value 
   Non-diabetic 
(control) Diabetics (case) 
Sex Male Count 24 21  
% within Group 68.6% 60.0% .454 
Female Count 11 14 
% within Group 31.4% 40.0%  
	   
TABLE 3 
Distribution of Basal Lower Esophageal Sphincter Pressures between Non-
diabetic and Diabetic group 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
   Group 
P value 
   Non-diabetic 
(control) Diabetics (case) 
Basal  
LOS  
Pressure 
Normal Count 25 26  
% within Group 71.4% 74.3% .777 
Elevated Count 2 3 
% within Group 5.7% 8.6%  
Reduced Count 
% within Group 
8 
22.9% 
6 
17.1% 
	   
TABLE 4 
Distribution of Esophageal Body Motility between Non-diabetic and Diabetic 
group 
 
   Group 
P value 
   Non-diabetic 
(control) 
Diabetics 
(case) 
Body  
Motility 
Propagative  Count 31 31  
% within Group 88.6% 88.6% 1.000 
Ineffective Count 4 4 
% within Group 11.4% 11.4%  
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
 
	   
TABLE 5 
Comparison of Mean Basal Inspiratory Pressure between Non-diabetic group 
and Diabetic group 
 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
 
Non-diabetic Group  
(n = 35) 
Diabetic group 
(n = 35) 
 
P value Mean ± SD Mean ± SD 
28.246 ±11.362 22.627 ±9.125 0.026* 
	  TABLE 6 
 
         Comparison of Mean Basal Expiratory Pressure between Non-diabetic 
group and Diabetic group 
 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
 
Non-diabetic Group  
(n = 35) 
Diabetic group 
(n = 35) 
 
P value Mean ± SD Mean ± SD 
17.617 ± 9.17 23.514 ± 9.66 0.011* 
	  TABLE 7 
Mann Whitney test to compare Mean Basal Expiratory Pressure levels in the 
Non-diabetics and Diabetics 
 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
Parameter 
Non-diabetic 
group 
Diabetic      
group 
Mann 
Whitney (U) 
 
P value 
 Mean rank Mean rank 
Mean Expiratory 
Pressure (mm of Hg) 
28.71 42.29 .005 0.005* 
	  TABLE 8 
Comparison of EGJ – CI  between Non-diabetic group and Diabetic group 
 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
 
 
 
Non-diabetic Group  
(n = 35) 
Diabetic group 
(n = 35) 
 
P value Mean ± SD Mean ± SD 
29.920 ± 19.001 31.68 ± 13.635 0.657 
	  TABLE 9 
 
Mann Whitney test to compare EGJ –CI levels in the Non-diabetics and 
Diabetics 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
 
Parameter 
Non-diabetic 
group 
Diabetic      
group 
Mann 
Whitney (U) 
 
P value 
 Mean rank Mean rank 
EGJ-CI 32.57 38.43 .229 0.229 
	   
TABLE 10 
Comparison of Median Integrated Pressure between Non-diabetic group and 
Diabetic group 
 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
 
Non-diabetic Group  
(n = 35) 
Diabetic group 
(n = 35)  
P value Mean ± SD Mean ± SD 
7.877 ± 5.886 6.337 ± 5.147 0.248 
	  TABLE11 
 
Mann Whitney test to compare Median Integrated Pressure levels in the  
Non-diabetics and Diabetics 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
 
Parameter 
Non-diabetic 
group 
Diabetic      
group 
Mann 
Whitney (U) 
 
P value 
 Mean rank Mean rank 
Median IRP 38.09 32.91 .288 0.288 
	  TABLE 12 
Comparison of Manometric Parameters between Males and Females in the  
Non-diabetic (Control) Group 
Parameters 
Males 
N = 24 
Females 
N = 11 P value 
Mean ± SD Mean ± SD 
Mean Expiratory Pressure 15.658 ± 6.372 21.891 ±12.766 
 
0.061 
 
EGJ- CI 27.597 ± 14.361 35.027 ± 26.672 0.288 
Median IRP 8.883 ± 5.440 5.682 ± 6.275 0.137 
 
* P-value < 0.05    -    statistically significant 
 
  
 
 
 
 
	  TABLE 13 
Mann Whitney test to compare manometric parameters between Males and 
Females in the Non-diabetic (Control) Group 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
Parameter 
Male Female 
Mann 
Whitney (U) 
 
P value 
 Mean rank Mean rank 
Mean Expiratory Pressure 16.54 21.18 .224 .224 
EGJ- CI 18.13 17.73 .930 .930 
Median IRP 20.52 12.50 .030 .030* 
	  TABLE 14 
Comparison of Manometric Parameters between Males and Females in the 
Diabetic (Case) Group 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
Parameters 
Males 
N = 21 
Females 
N = 14 P value 
Mean ± SD Mean ± SD 
Mean Expiratory Pressure 24.995 ± 11.022 21.293 ± 6.293 
 
0.273  
EGJ- CI 29.833 ± 13.910 34.464 ± 13.218 0.332 
Median IRP 6.648 ± 4.960 5.871 ± 5.572 0.669 
	  TABLE 15 
Mann Whitney test to compare manometric parameters between Males and 
Females in the Diabetic (Case) Group 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
 
Parameter 
Male Female 
Mann 
Whitney (U) 
 
P value 
 Mean rank Mean rank 
Mean Expiratory Pressure 19.33 16.00 0.359 0.359 
EGJ- CI 16.69 19.96 0.359 .0.359 
Median IRP 19.50 15.75 0.293 0.293 
	  TABLE 16 
Comparison of Manometric Parameters between those with HbA1c Values < 6.5 
and≥ 6.5 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
Parameters 
HbA1c < 6.5 
N = 6 
HbA1c ≥ 6.5 
N = 29 P value 
Mean ± SD Mean ± SD 
Mean Expiratory Pressure 25.900 ± 12.403  23.021± 9.181 
 
0.514  
EGJ- CI 22.300 ± 11.530 33.628 ± 13.388 0.063 
Median IRP 3.700 ± 2.480 6.883 ± 5.410 .171 
	  TABLE 17 
Mann Whitney test to compare manometric parameters between those with 
HbA1c Values < 6.5 or  ≥ 6.5 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
 
 
Parameter 
HbA1c < 6.5 
 
HbA1c ≥ 6.5 
 Mann 
Whitney (U) 
 
P value 
 Mean rank Mean rank 
Mean Expiratory Pressure 20.50 17.48 0.535 0.535 
EGJ- CI 10.50 19.55 0.050 0.050* 
Median IRP 12.33 19.17 0.146 0.146 
	  TABLE 18 
Comparison of Manometric Parameters between Diabetics whose duration of the 
disease is < 5 years (Group A) and ≥  5 years (Group B) 
 
 
* P-value < 0.05    -    statistically significant 
 
 
 
 
 
Parameters 
Group A  
< 5 years 
N = 9 
Group B 
≥  5 years 
N = 26 
P value 
Mean ± SD Mean ± SD 
Mean Expiratory Pressure 17.889 ± 5.372 25.462 ± 10.112 
 
0.041* 
EGJ- CI 34.733 ± 12.025 30.631 ± 14.215 0.445 
Median IRP 6.589 ± 6.827 6.250 ± 4.592 0.868 
	  TABLE 19 
Mann Whitney test to compare manometric parameters between Diabetics 
whose duration of the disease is < 5 years (Group A) and ≥ 5 years (Group B) 
 
 
 
* P-value < 0.05    -    statistically significant 
 
	  	  	  	  
Parameter 
Group A  
< 5 years 
 
Group B 
≥  5 years 
 
Mann 
Whitney (U) 
 
P value 
 
Mean rank Mean rank 
Mean Expiratory Pressure 11.67 20.19 0.031 0.031* 
EGJ- CI 20.33 17.19 0.446 0.446 
Median IRP 17.61 18.13 0.897 0.897 
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  CHART 1 
Age Distribution between Non-diabetics and Diabetics 
 
 
 
CHART 2 
Sex Distribution between Males and Females in Control and Case Groups 
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  CHART 3 
Distribution of Body Motility between Control and Case Groups 
 
 
  
 
CHART 4 
Mean Basal Expiratory Pressure between Non-diabetics and Diabetics 
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  CHART 5 
EGJ - CI between Non-diabetics and Diabetics 
 
 
 
CHART 6 
Median IRP between Non-diabetics and Diabetics 
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  CHART 7 
Mean Basal Expiratory Pressure in Non-diabetic Male & Female 
 
 
 
CHART 8 
EGJ- CI in Non-diabetic Male & Female 
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  CHART 9 
IRP in Non-diabetic Male & Female 
 
 
 
CHART 10 
Mean Basal Expiratory Pressure in Diabetic Male & Female 
 
   
0 
4 
8 
12 
16 
20 
Males Females 
M
ea
n 
± 
SD
 
IRP  in Non-diabetic Group 
0 
10 
20 
30 
40 
50 
60 
Males Females 
M
ea
n 
± 
SD
 
Mean Basal Expiratory Pressure in  Diabetic Group 
 
P value 0.137 
 
P value 0.273 
 
	  CHART 11 
EGJ-CI in Diabetic Male & Female 
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IRP in Diabetic Male & Female 
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  CHART 13 
Mean Basal Expiratory Pressure in uncontrolled and controlled Diabetics   
 
 
 
CHART 14 
EGJ- CI in uncontrolled and controlled Diabetics   
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  CHART 15 
IRP in uncontrolled and controlled Diabetics   
 
  
 
CHART 16 
Mean Basal Expiratory Pressure in Duration of Diabetes > 5 years and < 5 years   
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  CHART 17 
EGJ -CI in Duration of Diabetes > 5 years and < 5 years   
 
 
 
   
CHART 18 
IRP in Duration of Diabetes > 5 years and < 5 years   
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  Discussion 
It is within human nature and for the betterment of science that controversial 
findings or statements are not ignored. May the findings that one comes will create 
more controversy finally down the timeline, these are the foundations that get created 
for one to make a discovery and end the controversy giving rise to a new proven 
theory.  It is the scientist within each one of us who tries to come up with this new 
proven theory that can maybe even change the world one day. 
One of the longest autonomic nerves present in the human body is the tenth 
cranial nerve, the vagus Nerve. It has been known to be historically cited as the 
pneumogastric nerve. Its supply to the digestive tract and has proven to be imperative 
for many physiological functions.  Gastrointestinal symptoms have been attributed 
due to motor dysfunction, which results from autonomic (vagal) neuropathy. (65) Vela 
et al reinforces by stating that the esophagus is part of the alimentary tract that is 
highly supplied by the vagus, but whose functional activity in those with diabetes has 
been neglected. (66) 
Diabetes has been present for centuries, and within this long duration many 
advances have been seen with regard to treatment and control of this disease. 
Likewise Gastro esophageal Reflux Disease has also been prevalent for countless 
years, with treatment ranging from something as simple as home remedies to 
something as complex as surgical intervention. Tying up these two diseases and 
seeing if there lies a correlation between GERD and the presence of Diabetes was the 
	  aim of our study. Nishida et al comments that the incidence of GERD in patients with 
Diabetes Mellitus remains controversial. (67) It is this controversy that has led us into 
this study.  
Age in Relation to Non Diabetics and Diabetics with GERD 
In our study, there was no statistical significant difference in mean age of the 
subjects who were present in both groups. This shows that both the groups are age 
matched. The mean age was found to be 51 in non-diabetics and 54 in diabetics, 
which seemed to be similar to a study conducted by Wang et al and team in a 
population based study to see the prevalence of GERD in southern India. Wang et al 
found that 22.2% of the general population from southern India there was significant 
association between presence of GERD with increasing age. (68) 
Sex in Relation to Non Diabetics and Diabetics with GERD 
 In our study, there was no statistical significance found between males and 
females within each group. Nishida et al found there was no significant difference in 
the incidence of reflux symptoms between males and females. (67) Mayne et al found 
that GERD associated with diabetes occurs three to four times more often than in the 
general population of a similar age and sex. (69) On the contrary Janatuinem et al 
demonstrated that the spectrum of gastrointestinal symptoms in diabetes is similar and 
does not differ from that in the general population. (70) 
  
	  Body Motility in Relation to Non-Diabetics and Diabetics with GERD 
88.6% of the study group and 88.6% of the control group showed propagative 
movements and 11.4% in both the groups showed ineffective motility and on 
comparison there was no statistical significance. In a study conducted by Jorge et al, 
comparison of esophageal motor characteristics between diabetics and healthy 
individuals were conducted. It was found that maximum active tension in healthy 
individuals reduces due to age and in other words the esophagus becomes stiffer with 
age. Increased stiffness is associated with reduction in primary and secondary 
peristalsis in a healthy individual after the age of 40 years. (71) The mean age in both 
groups in our study was 51 in the control group and 54 in the study group. Vela et al 
found in his manometric examination of the esophagus that significant change was 
present in diabetics who had esophageal motor alterations. He felt that these motor 
alterations would add to a functional obstruction, which affects the transport of 
esophageal contents thereby delaying the esophageal emptying. Despite the high 
incidence of esophageal motor disturbances the patients in the study conducted by 
Vela had no referable symptoms. (66) Feldman et al found in a study that 22% of 
asymptomatic diabetic patients had radiologic evidence of gastric retention, due to 
delayed gastric emptying. This is attributed to various causes; one of such is poor or 
no esophageal peristalsis. The only logical reason behind this being damage to the 
vagus due to autonomic neuropathy. These findings are found to be similar with that 
of ones seen after truncal vagotomy. (59) 
	  Basal lower esophageal sphincter pressure between non-diabetic and diabetic 
group 
The basal lower esophageal sphincter pressure is classified according to a range. The 
normal value falls within the pressure range of 10-35 mm of Hg. A value above 35 
mm of Hg is considered as elevated and a value below 10 mm of Hg is considered as 
reduced. More than 70 % of the non-diabetic and diabetic group showed pressures to 
be within the normal range. Elevated pressures were found to be 5.7% in the control 
group and 8.6% in the study group. Reduced pressures were 22.9% in the control 
group and 17.1% in the study group. 
Mean Basal Inspiratory Pressure in Relation to Non-Diabetics and Diabetics 
with GERD 
 In our study, there was a statistically significant p value obtained while 
comparing the mean basal inspiratory pressures in both control and case groups. The 
mean basal expiratory pressure is the standard pressure recording taken for lower 
esophageal sphincter pressure readings; therefore no studies have discussed the values 
and significance of mean basal inspiratory pressures.  However, due to its statistical 
significance its value may hold significance. The mean value for the study group was 
increased, when compared to the control group but still within the normal range of 
pressures.  
	  Mean Basal Expiratory Pressure in Relation to Non-Diabetics and Diabetics with 
GERD 
 The mean basal expiratory pressure recorded in this present study showed there 
to be statistical significance between the two study groups. However, the control 
group showed mean values to be of 17 mm of Hg when compared to the diabetic 
group, which had a mean of 23 mm of Hg. Both these values come under the normal 
range of 10-35 mm of Hg for basal expiratory pressure. In a study conducted by 
Stewart et al the lower esophageal sphincter pressure was significantly reduced in all 
groups of diabetics when compared with non-diabetics. Stewart et al and team 
however conducted the study in diabetics with known neuropathic complications and 
went one step further to find out that there was no difference in those who had 
diabetes with and without autonomic symptoms. (72) In a study conducted by Lluch et 
al found that there was a higher prevalence of abnormal gastro esophageal reflux in 
asymptomatic diabetics when compared to the general population. (73) However, in our 
study both the groups were symptomatic that could be the reason for the control group 
having a low value of mean basal expiratory pressure.   
Comparison of EGJ-CI between non diabetics and diabetics 
In our study, the mean value for the EGJ – CI was found to be 29.920 mm of Hg in 
the control group and slightly higher around 31.68 mm of Hg in the diabetic study 
group. This showed no statistical significance when subjected to t test as well as 
Mann Whitney test. Ham et al in a study conducted between patients with GERD and 
	  healthy individuals found that the EGJ –CI value was lower in patients with GERD 
(around 22.6 mm of Hg) when compared to those without GERD having a value of 
50.3 mm of Hg. (74) There is no other study evidence, which discusses the effect of 
diabetes on the EGJ – CI. However in our study it shows that the diabetic group had a 
slightly raised value of 31.68 mm of Hg when compared to the control group.  
Comparison of the Median Integrated Pressures between non diabetics and 
diabetics 
In our study the median integrated pressure was found to be 7.87 mm of Hg in the 
control group and a slightly lower value of 6.33 mm of Hg in the diabetic group. 
Upon comparison there was no statistical significance found. A value above 15 mm of 
Hg is considered to be pathologic. (34) In our study, in both groups it falls within the 
normal range.  
Comparison of Manometric Parameters between Males and Females in the Non 
Diabetic (Control) Group 
In our study, the mean basal expiratory pressure was found to be statistically 
insignificant, when comparison was done between males and females in the control 
group. The mean age for males in our study was for the control group was 44 years 
and for females was 38 years. In a study conducted by Kim et al, he states that the 
prevalence of reflux esophagitis is significantly increased only as age increases in 
females, and this may be due to the decrease in estrogen levels post menopause. (64) 
	  Since the mean age of women in our study was within the reproductive age group it 
maybe the reason for normal expiratory pressures.  
The median integrated relaxation pressure is a metric used in HRM in order to assess 
the adequacy of esophagogastric junction. The integrated relaxation pressure has been 
defined as the lowest pressure through the EGJ for four contiguous or non-contiguous 
seconds within the relaxation window. This value incorporates both a measure of the 
completeness of relaxation and the duration of time for which this relaxation is 
sustained. (75) In our study the median IRP was decreased in males compared to 
females. This is attributed to the presence of estrogen in females, which increases 
smooth muscle contraction. Upon performing the Mann Whitney test for median IRP 
among males and females in the control group a p value of 0.030 was obtained 
showing statistical significance. Costa et al found that the IRP in women and men had 
no statistical significance. (76) Like in our study Costa also found no statistical 
significance between men and women for median IRP, this he attributed to the 
possibility of decreased number of subjects, which could also be the same in out 
study. Only upon the Mann Whitney non-parametric comparison did the median IRP 
show statistical significance between male and female.  
None of the same parameters showed statistical significance in the diabetic study 
group, in the current study. This may be attributed to the fact that in the control group 
the mean age for women was found to be 38, which is within the reproductive age 
group showing their presence of estrogen; however the males in the control group 
	  were older with a mean age of 56. In the study group the mean age for women was 
calculated to be 51, which mean they have entered the menopausal age group with 
reduction in estrogen function. The males in the study group had a mean age of 56, 
therefore when comparison was carried out between both male and female with all 
manometric parameters in the study group no statistical significance was found.  
Comparison of Manometric Parameters between those with HbA1c Values < 6.5 
or ≥ 6.5 
In our study more than 80 % of the study group had an HbA1c value of greater than 
6.5 and were not in glycemic control. Nishida et al comments that the incidence of 
GERD is higher in patients with diabetes regardless of the complications of diabetes. 
Based upon a questionnaire study the HbA1c was positively associated with the 
incidence of symptomatic GERD. (67) 
However in our study upon comparison of various manometric parameters, mean 
expiratory pressure and IRP showed no statistical significance, but the EGJ- CI 
showed statistical significance. There are no studies that comment on the EGJ –CI of 
diabetic individuals regardless of their glycemic control.  
Comparison of Manometric Parameters between Diabetics whose duration of the 
disease is < 5 years and ≥ 5 years  
Nishida et al states that the incidence of GERD is related to the duration of diabetes 
mellitus. (67) The mean expiratory pressure was increased in those who were diabetic 
	  for more than five years when compared to those who were diabetic for more than 
five years. This increase was significant in both t test and Mann Whitney test. More 
than 70% of diabetic patients had diabetes for more than 5 years. Less than 30% of 
the individuals were within duration of 5 years. However there was no statistical 
difference in the EGJ-CI and IRP values in relation to the duration of diabetes 
mellitus.  
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  CONCLUSION: 
 As mentioned previously controversy can lead to the discovery of new 
information and theories, which sets forth a path towards the betterment of treatment. 
With the high prevalence of diabetes and gastro esophageal reflux disease it lies 
crucial to find a reason and create a solution for these issues. 
The age in our study was matched therefore showing in comparison with other 
studies that with increasing age there lay an increase in the incidence of GERD as age 
progresses regardless of the presence of diabetes mellitus. Gender in relation to the 
control group and diabetic group was also found to be matched. This gave proper 
comparison when esophageal parameters were checked between males of the two 
groups and females of the two groups. The comparison of these parameters is 
discussed below.  
More than 80% of both study and control groups had propagative motility 
unlike various other studies, which showed, decreased motility. Above 70% of the 
control and study group showed normal basal lower esophageal sphincter pressures 
and the rest had either hypertensive sphincter pressures or hypotensive sphincter 
pressures.  
Mean basal inspiratory pressure was increased in the study group when 
compared to that of the control group but was within the normal range.  
	  On comparison of mean expiratory pressure between males and females in the 
non diabetic group the females had high values when compared to the males, this may 
be due to the benefits of estrogen as mentioned above, and that all the women in the 
control group were within the reproductive age group.  
 The EGJ-CI denotes the esophagogastric junction barrier function. On 
comparison between those who were under the HbA1c value of less than 6.5 gms/dL 
and above 6.5 gm/dL the uncontrolled diabetic patients showed a high mean rank 
when compared to those who had glycemic control. These results may help to prove 
that uncontrolled diabetes may lead to complication of diabetes, one of which is 
autonomic gastro neuropathy due to the damage of the vagus nerve.  
 Regarding the duration of diabetes, mean expiratory pressures were lower in 
diabetics less than five years duration when compared with those who were diabetic 
for more than 5 years. This may be attributed to the fact that those who have had 
diabetes for a shorter duration still had not established proper glycemic control when 
compared to those who have had diabetes for longer duration. However this is not a 
definitive result, as comparison should be done between the short duration and 
glycemic control for conclusive statements to be made.  
 It was found in our study, even though certain manometric parameters had 
statistical significance they all fell within the normal range. This shows that the 
presence of diabetes has an impact on these manometric parameters, and age related 
changes occur irrespective of glycemic control. Even though the data found in this 
	  study can be helpful in adding to the controversies which lie between GERD and its 
association with diabetes mellitus, it can be helpful in coming to a conclusion about 
the duration and control of diabetes and its effect on upper gastrointestinal symptoms.  
To further validate this study, it can be continued over a longer duration of time with 
more number of patients and also with the addition of healthy volunteers to undergo 
high-resolution esophageal manometry in order to come to a definite conclusion.	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  ANNEXURE I 
 
DATA COLLECTION TOOL: 
OP NO:       IP NO: 
PHONE NUMBER: 
Name: 
Age: 
Sex: 
BMI:                           HT:    WT:  
Type II DM : YES         NO 
DURATION OF TYPE II DM: 
HbA1c Value:                                                 Date last checked: 
ON ANY MEDICATION:     YES NO 
NAME OF DRUGS: 
OTHERS:  
 
	  ANNEXURE II 
 
PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS 
 
 
 
I / We (write name of the investigator(s) here), Dr. R Pavitra Vyshnavi Yogisparan_, am / are carrying out 
a study on the topic: Lower Esophageal Sphincter Pressure in patients with type II Diabetes Mellitus 
presenting with heartburn as part of my / our research project being carried out under the aegis of the 
Department of: Physiology & Gastroenterology  
 
(Applicable to students only): My / our research guide is: Dr. T. Umamaheshwari 
 
The justification for this study is:  
 
To find out the association of upper gastrointestinal symptoms in patients with type II diabetes who live 
in India. There are not many studies done to see this association in the Indian Phenotype of type II 
Diabetes Mellitus Patients.  
 
 
The objectives of this study are:  
 
Primary Objective: 
To evaluate the Lower Esophageal Sphincter Pressure in patients with Type II Diabetes Mellitus, 
presenting with heartburn, by esophageal manometry studies and 24 hour esophageal pH monitoring.  
 
Secondary Objective:  
1. To find the correlation between the severity of the GI symptoms and severity of  type II diabetes 
mellitus by use of glycemic index.  
2. To determine whether these tests can be used as early indicators of GERD (Gastro-esophageal 
Reflux Disease) in patients with Type II Diabetes Mellitus. 
3. To study the pathophysiology of gastro esophageal reflux symptoms in patients with type II 
diabetes.  
 
 
 
	  Sample size: 60 
 
 
Study volunteers / participants are (specify population group & age group): 30 Type II Diabetic patients 
and 30 Non-diabetic patients presenting with heartburn.  
 
Location: Gastroenterology Dept, PSGIMSR, Coimbatore 
 
Benefits from this study: To find out for future patients with type II diabetes how to prevent and 
manage heartburn.  
 
Risks involved by participating in this study:NIL 
 
How the results will be used: For my dissertation study. 
 
If you are uncomfortable in answering any of our questions during the course of the interview / biological 
sample collection, you have the right to withdraw from the interview / study at anytime. You have the 
freedom to withdraw from the study at any point of time. Kindly be assured that your refusal to participate or 
withdrawal at any stage, if you so decide, will not result in any form of compromise or discrimination in the 
services offered nor would it attract any penalty. You will continue to have access to the regular services 
offered to a patient. You will NOT be paid any remuneration for the time you spend with us for this interview 
/ study. The information provided by you will be kept in strict confidence. Under no circumstances shall we 
reveal the identity of the respondent or their families to anyone. The information that we collect shall be 
used for approved research purposes only. You will be informed about any significant new findings- 
including adverse events, if any, – whether directly related to you or to other participants of this study, 
developed during the course of this research which may relate to your willingness to continue participation. 
 
Consent: The above information regarding the study, has been read by me/ read to me, and has been 
explained to me by the investigator/s. Having understood the same, I hereby give my consent to them to 
interview me. I am affixing my signature / left thumb impression to indicate my consent and willingness to 
participate in this study (i.e., willingly abide by the project requirements).  
 
Signature / Left thumb impression of the Study Volunteer / Legal Representative:  
 
 
 
Signature of the Interviewer with date:      Witness: 
 
Contact number of PI: 
 
Contact number of Ethics Committee Office:  0422 2570170 Extn.: 5818 	  	  	  	  
	  ANNEXURE III 
 
 
 
 
Xg;Gjy; gbtk; 
 
                             Njjp: 
 
lhf ;lh ; . gtpj ;uh it\;ztp Nahf P];gud; Mfpa ehd; 
PSG kUj;Jtf;fy;Yhhpapy; clypaq;fpay; Jiwapd; fPo; 
“e Pu po pT Nehahspfspy ; neQ;nrhpr ;ry ; mwpFwp 
cs;sth ;fSf;F Fiwe;j czTf;Foha; RUf;fj ;jir 
mOj;jj ;ij fz;lwpjy;” vd;w jiyg;gpy; Ma;T 
Nkw;nfhs;s cs;Nsd;. 
 
vd; Ma;T topfhl;b:  lhf ;lh ; . b. ckh kNf];thp 
 
Ma;T Nkw;nfhs;tjw;f;fhd mbg;gil: Nky; ,iug ;ig 
mwpFwpfSf;Fk ; e PuopT Neha ;f ;Fk ; rk ;ge ;jk ; cs;s 
Ma;Tfs; ,e ;jpahtpy ; kpf FiwthfNt cs;sd. 
mjdhy; ,e ;j Ma;it Nkw ;nfhs;fpNwd; . 
 
Ma;tpd; Nehf;fk;:  Nky; ,iug ;ig mwpFwpfSf;Fk; > 
e PuopT Neha ;f ;Fk ; rk ;ge ;jk ; cs;sjh vd;gij 
xg ;g pl ;L ghh ;j ;J fz;Lgpbf ;f Ntz;Lk ; . 
 
Ma;tpy; gq;F ngWk; egh;fspd; vz;zpf;if:  60 (mWgJ) 
 
Ma;T Nkw;nfhs;Sk; ,lk;: clypaq;fpay; kw ;Wk ; 
,iug ;ig Flypapy ; gph pT. 
 
Ma;tpd; gyd;fs;: e PuopT Nehahspfspy ; > Nky; 
,iug ;ig mwpFwpfis tuhky; jtph ;f ;f KbAk; 
kw ;Wk ; mij ed;Kiwapy ; Fzg;gLj ;j KbAk; . 
 
Ma;tpdhy; Vw;gLk; mnrsfhpaq;fs; / gf;f tpisTfs;: 
 
ve ;j tpjkhd gf;f tpisTfSk; ,y;iy. 
 
,e;j Ma;tpy; fpilf;Fk; jfty;fs; Ie ;J tUlq;fs; 
ghJfhf;fg;gLk;. ,it NtW ve;j Ma;tpw;f;Fk; 
gad;gLj;jg;gl khl;lhJ. Ve;j epiyapYk; cq;fisg; gw;wpa 
jfty;fs; ahUf;Fk; njhptpf;fg;glkhl;lhJ. mit ufrpakhf 
itf;fg;gLk;. 
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þó¾ ¬öÅ¢ý §¸ûÅ¢¸ÙìÌ À¾¢ÄÇ¢ôÀ¾¢§Ä¡, þÃò¾ Á¡¾¢Ã¢¸û «øÄÐ ¾¢Í Á¡¾¢Ã¢¸û 
±ÎôÀ¾¢§Ä¡ ?í¸ÙìÌ ²§¾Ûõ «¦ºª¸Ã¢Âí¸û þÕó¾¡ø, ±ó¾ §¿Ãò¾¢ø §ÅñÎÁ¡É¡Öõ 
¬öÅ¢Ä¢ÕóÐ Å¢Ä¸¢ì¦¸¡ûÙõ ?Ã¢¨Á ?í¸ÙìÌ ?ñÎ. ±ô¦À¡ØÐ §ÅñÎÁ¡É¡Öõ 
¬öÅ¢Ä¢ÕóÐ Å¢ÄÌõ ?Ã¢¨Á ?í¸ÙìÌ ?ûÇÐ. ¬öÅ¢Ä¢ÕóÐ Å¢Ä¸¢ì¦¸¡ûÅ¾¡ø ?í¸ÙìÌ 
«Ç¢ì¸ôÀÎõ º¢¸¢î¨º Ó¨ÈÂ¢ø ±ó¾ Å¢¾ À¡¾¢ôÒõ þÕì¸¡Ð ±ýÚ ?í¸ÙìÌ 
?Ú¾¢ÂÇ¢ì¸¢§È¡õ. ÁÕòÐÅ Á¨ÉÂ¢ø §¿¡Â¡Ç¢¸ÙìÌ «Ç¢ì¸ôÀÎõ §º¨Å¸¨Ç ¿£í¸û 
¦¾¡¼÷óÐ ¦ÀÈÄ¡õ. þó¾ ¬öÅ¢ø Àí§¸ü¸ ´ôÒì¦¸¡ûÙÅ¾¡ø §ÅÚ ±ó¾ Å¢¾Á¡É 
ÜÎ¾Ä¡É ÀÄÛõ ?í¸ÙìÌì ¸¢¨¼ì¸¡Ð. ¿£í¸û «Ç¢ìÌõ ¾¸Åø¸û þÃ¸º¢ÂÁ¡¸ 
¨Åì¸ôÀÎõ. ¬öÅ¢ø Àí§¸üÀÅ÷¸û ÀüÈ¢§Â¡ «Å÷¸û ÌÎõÀò¨¾ô ÀüÈ¢§Â¡ ±ó¾ò ¾¸ÅÖõ 
±ì¸¡Ã½õ ¦¸¡ñÎõ ¦ÅÇ¢Â¢¼ôÀ¼¡Ð ±ýÚ ?Ú¾¢ÂÇ¢ì¸¢§È¡õ. ¿£í¸û «Ç¢ìÌõ ¾¸Åø¸û / 
þÃò¾ Á¡¾¢Ã¢¸û / ¾¢Í Á¡¾¢Ã¢¸û «í¸£¸Ã¢ì¸ôÀð¼ ¬öÅ¢üÌ ÁðÎ§Á ÀÂýÀÎò¾ô ÀÎõ. þó¾ 
¬ö× ¿¨¼¦ÀÚõ ¸¡Äò¾¢ø ÌÈ¢ôÀ¢¼ò¾Ìó¾ Ò¾¢Â ¸ñÎÀ¢ÊôÒ¸û «øÄÐ Àì¸ Å¢¨Ç×¸û 
²Ðõ ²üÀð¼¡ø ?í¸ÙìÌò ¦¾Ã¢Å¢ì¸ôÀÎõ. þ¾É¡ø ¬öÅ¢ø ¦¾¡¼÷óÐ ÀíÌ ¦ÀÚÅÐ 
ÀüÈ¢Â ?í¸û ¿¢¨ÄôÀ¡ð¨¼ ¿£í¸û ¦¾Ã¢Å¢ì¸ ²ÐÅ¡Ìõ. 
 
¬ö×ìÌðÀÎÀÅÃ¢ý ´ôÒ¾ø: þó¾ ¬ö¨Åô ÀüÈ¢Â §ÁüÜÈ¢Â ¾¸Åø¸¨Ç ¿¡ý ÀÊòÐ 
«È¢óÐ ¦¸¡ñ§¼ý / ¬öÅ¡Ç÷ ÀÊì¸ì §¸ðÎò ¦¾Ã¢óÐ ¦¸¡ñ§¼ý. ¬öÅ¢¨Éô ÀüÈ¢ 
¿ýÈ¡¸ô ÒÃ¢óÐ ¦¸¡ñÎ þó¾ ¬öÅ¢ø ÀíÌ ¦ÀÈ ´ôÒì¦¸¡û¸¢§Èý. þó¾ ¬öÅ¢ø 
Àí§¸üÀ¾ü¸¡É ±ÉÐ ´ôÒ¾¨Ä ¸£§Æ ¨¸¦Â¡ôÀÁ¢ðÎ / ¨¸ §Ã¨¸ À¾¢òÐ ¿¡ý ¦¾Ã¢Å¢òÐì 
¦¸¡û¸¢§Èý.  
 
Àí§¸üÀ¡ÇÃ¢ý ¦ÀÂ÷, Ó¸ÅÃ¢ : 
 
 
 
Àí§¸üÀ¡ÇÃ¢ý ¨¸¦Â¡ôÀõ / ¨¸ §Ã¨¸ / ºð¼â÷Å À¢Ã¾¢¿¢¾¢Â¢ý ¨¸¦Â¡ôÀõ :    
    
§¾¾¢     : 
 
 
¬öÅ¡ÇÃ¢ý ¨¸¦Â¡ôÀõ  :  
§¾¾¢     :       
 
¬öÅ¡ÇÃ¢ý ¦¾¡¨Ä§Àº¢ ±ñ: 
 
ÁÉ¢¾ ¦¿È¢Ó¨Èì ÌØ «ÖÅÄ¸ò¾¢ý ¦¾¡¨Ä§Àº¢ ±ñ: 0422 2570170   Extn.: 5818 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  ANNEXURE IV 	  
 	  
S.#NO AGE SEX
Basal*
LOS*
Pressure
Mean*
Basal*
Insp*Pr
Mean*
Basal*
Exp*Pr EGJ7Cl
Median*
Integrated*
Relaxation*
Pressure Body*Motility
1 55 M Normal 34.2 11.4 25.6 4.1 Propagative
2 37 M Normal 19.5 20.2 22.3 12.1 Propagative
3 57 M Normal 38.5 16.5 31.1 5.2 Propagative
4 40 M Normal 30.1 16.6 24.9 6.1 Ineffective
5 57 F Reduced 14.7 17.6 18.2 0.5 Propagative
6 76 F Normal 28.2 22.9 29.8 0.1 Propagative
7 47 M Normal 34.8 11.7 30.8 7.3 Propagative
8 65 M Normal 22.8 27.8 38.2 12.6 Propagative
9 37 F Elevated 45 45.2 95.1 8.6 Propagative
10 44 F Normal 14.1 25.8 27.1 4.6 Propagative
11 53 M Normal 14 19 18.8 9.9 Propagative
12 53 M Normal 22.3 15.1 18.9 1.7 Propagative
13 42 M Normal 33.9 27.6 37.9 13.3 Propagative
14 42 M Reduced 11 8.5 3.1 1.6 Propagative
15 44 M Reduced 9.4 10.5 10.9 9.5 Propagative
16 62 M Normal 40.6 18.2 51.2 9.3 Propagative
17 57 F Reduced 47.7 5 17.9 2.8 Ineffective
18 40 F Normal 31.9 22.3 50.5 6.5 Propagative
19 59 M Reduced 15.7 5.2 8.5 3.6 Propagative
20 50 M Reduced 35.1 8.6 22.7 11.3 Propagative
21 37 M Reduced 17.3 9.2 21 10.5 Propagative
22 51 M Normal 21.1 11.8 12.7 4.5 Propagative
23 52 F Elevated 52.8 41 73.4 23.1 Propagative
24 40 F Reduced 32.5 9.9 20.4 3.4 Propagative
25 39 M Normal 40.6 23.2 45.5 25.9 Propagative
26 54 F Normal 21.9 10.3 17.5 5.6 Propagative
27 74 M Normal 33.2 17 59.9 16 Propagative
28 51 M Normal 20.5 10.1 18.6 6.8 Propagative
29 59 F Normal 19.9 28.1 16.1 4 Ineffective
30 52 M Normal 34.1 12.8 31.1 13.2 Propagative
31 44 F Normal 29.8 12.7 19.3 3.3 Propagative
32 72 M Normal 16.9 13.8 21.3 4 Propagative
33 57 M Normal 22.3 15.1 18.9 1.7 Propagative
34 46 m Normal 34.4 17.1 51.4 10.4 Ineffective
35 48 M Normal 47.8 28.8 36.6 12.6 Propagative
Non7diabetic*(Control)*Group
	  ANNEXURE V	  	  	  	  	  
S.NO AGE SEX
Basal*LOS*
Pressure
Mean*
Basal*
Insp*Pr
Mean*
Basal*
Exp*Pr EGJ7Cl
Median*
Integrated*
Relaxation*
Pressure
Body*
Motility HbA1c Duration
1 59 M Normal 16.7 15.7 28.4 1.5 Propagative 12 10
2 64 F Normal 22.5 21.2 22.7 0 Propagative 7.8 8
3 71 M elevated 16.4 44.7 21.4 7.8 Propagative 6.3 7
4 49 M Reduced 17.7 32.1 23.9 11.5 Propagative 9.2 20
5 55 M Normal 25.7 27.7 44.2 12.8 Propagative 6.7 4
6 56 F Normal 31 28.2 58.2 3.6 Propagative 7.9 12
7 62 M Reduced 19.2 26.2 57 10.7 Propagative 8 5
8 63 F Normal 26.4 27.8 43.9 7.6 Propagative 6.7 8
9 70 M Normal 21.2 30.4 34.1 3.3 Propagative 8 10
10 48 M Normal 24.2 29.5 30.8 19.3 Propagative 7.5 8
11 53 M Normal 22.4 31.1 54.7 5.7 Propagative 7.9 5
12 37 F Normal 38.1 23.3 55 4.4 Propagative 7.2 1
13 65 M Normal 21.8 18.2 24.8 10.3 Propagative 10.9 15
14 67 F Normal 24.8 11.7 22 5.1 Propagative 7 13
15 36 F Normal 35.9 20.4 41.3 19.2 Propagative 9.3 2
16 33 F Normal 14.8 11.5 22.1 2.4 Propagative 6.8 1
17 45 F Normal 28.1 18.8 25.3 12.1 Propagative 7.2 15
18 37 M Normal 19.1 15.1 21.1 9.3 Propagative 9 2
19 59 M Normal 46.1 15.4 31.3 9.9 Ineffective 9 4
20 74 M Normal 20.7 10.1 7.3 0.8 Ineffective 6.7 10
21 47 F Normal 17.6 11.9 20.2 1.5 Propagative 9.8 4
22 63 M Reduced 13.1 8.2 13 4.7 Propagative 6.1 8
23 42 M Normal 24.5 15.8 41.3 D3.2 Propagative 8.8 4
24 67 F Normal 45.5 22.1 30.5 4 Propagative 7.2 12
25 46 F Normal 30.5 19.9 36.1 3 Propagative 7.3 3
26 54 M Normal 34.7 23 47.2 7.8 Propagative 7.2 10
27 55 M Normal 18 12.9 15 5.9 Propagative 10.5 7
28 65 F Normal 20.4 36.6 43.5 14.5 Propagative 7.2 12
29 67 M elevated 15.7 45.2 39.6 4.7 Ineffective 9.3 15
30 45 M Reduced 12.7 22.4 17.9 6.4 Ineffective 12 10
31 60 M elevated 11.8 43.4 35.8 5.5 Propagative 6.5 12
32 53 M Normal 10.1 33.9 26.5 4.2 Propagative 6.4 8
33 52 F Normal 21.8 24.5 42.9 2 Propagative 5.2 6
34 38 M Reduced 11.6 23.9 11.2 0.7 Propagative 5 5
35 41 F Reduced 11.5 20.2 18.8 2.8 Propagative 4.9 5
Diabetic*(Case)*Group
